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Abstract
Using a modified gene trap strategy, a novel factor involved in mRNA processing, 
USSRp58, was identified. Analysis of the USSRp58 sequence revealed that it contains an 
RS domain, common to factors involved in pre-mRNA splicing, and more generally in 
RNA processing. The subcellular localisation of the endogenous USSRp58 protein, as well 
of transiently expressed epitope-tagged USSRp58 protein, revealed that this protein 
localises to nuclear speckles, which suggests a potential role in pre-mRNA splicing. Two- 
hybrid analysis and immunoprécipitation/We stern blot assays have been used to 
demonstrate that USSRp58 interacts with different proteins that have either potential or 
clearly defined functions in splicing. Immunoprécipitation experiments revealed that 
USSRp58 also interacts with spliceosomal snRNPs, indicating that it is physically 
associated with the splicing apparatus. Using in vivo and in vitro splicing assays, USSRp58 
was shown to be functionally involved in splicing. Transient overexpression of USSRp58 
in cultured cells and analysis of the alternative splicing of an adenovirus El A reporter 
indicated that the protein can regulate 5' splice site selection in vivo. Furthermore, nuclear 
extracts immunodepleted of USSRp58 are unable to perform the second step of splicing in 
vitro, suggesting that this protein is necessary for this step.
A final set of results describing a nuclear retention signal (NRS) in the RS domain of 
SC35 was also included in this thesis. Chimeric proteins in which the RS domain of a non­
shuttling SR protein, SC35, was fused to either hnRNP A1 or SF2/ASF (both shuttling 
proteins), were used to demonstrate that an NRS was present in the RS domain of SC35. 
Analysis of deletion mutants of SC35 indicated that the NRS is comprised in the last 30 
amino acids of the protein. Finally, fusion of the NRS found in SC35 to SF2/ASF showed 
that this NRS is both portable and dominant.
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Introduction
1.1. Gene expression and RNA processing
In order to make proteins, living organisms must copy the genetic information from a 
DNA template into an RNA transcript. In eukaryotes, these RNA transcripts must undergo 
three major processing events in the nucleus before they can be transported to the 
cytoplasm, where they will be recognized by the translation machinery as fully translatable 
mRNAs.
In eukaryotes, gene expression begins with transcription of protein-encoding genes 
by RNA polymerase II (RNA pol II) to make mRNA precursors (pre-mRNAs). The nascent 
pre-mRNA acquires a cap structure at the 5' terminus by the capping machinery, non­
coding intervening sequences called introns must be removed through a process called 
splicing, and the 3' end of the transcript must be cleaved and polyadenylated. The mature 
mRNA can be then released from the site of transcription and exported to the cytoplasm for 
translation. Distinct machines are responsible for each of these processes, and this sequence 
of processing events, also includes an RNA surveillance system that ensures that aberrantly 
processed pre-mRNAs are eliminated.
It was originally considered that each of these processes occured post- 
transcriptionally and were independent of each other. However, over the past few years, 
reports from several laboratories have suggested that these reactions can influence each 
other and that they are tightly linked to transcription. It is now believed that most RNA
11
processing events occur co-transcriptionally (for recent reviews see Bentley, 2002; 
Maniatis and Reed, 2002; Proudfoot et al., 2002).
This thesis will focus on the functional characterisation of trans-acting factors 
involved in pre-mRNA splicing.
1.2. Splicing
The discovery that eukaryotic genes are interrupted by blocks of sequence that are not 
used for producing proteins occurred more than 25 years ago (Berget et al., 1977; Chow et 
al., 1977). When analysed on the electron microscope, bulges were observed on RNA/DNA 
heteroduplexes prepared by hybridisation of adenovirus genomic DNA and cellular RNAs 
prepared from cells infected with the virus. Segments of sequence that were found together 
at the mRNA level, were shown to be interrupted at the DNA level. This result implied the 
existence of a process that should be in charge of removing the intervening sequences that 
were not found in the cytoplasmic mRNA. This process was named splicing.
The genes of all eukaryotic organisms contain these intervening non-coding 
sequences, called introns, that need to be removed in order to join together the blocks of 
coding sequence, called exons, to generate a functional mRNA. The complexity of the 
process and number of spliced genes increases with the complexity of the organisms. In the 
yeast Saccharomyces cerevisiae only about 250 genes contain introns, and most of these 
intron-containing genes have only one small intron. In humans, more than 99% of the genes 
are interrupted by introns, and the number and size of these vary enormously.
The splicing reaction is carried out by a macromolecular complex, the spliceosome. 
This megacomplex consist of five uridine-rich small nuclear ribonucleoprotein complexes
12
U l, U2, U4, U5 and U6 snRNPs, and a large number of non-snRNP associated proteins. 
The spliceosome is a highly dynamic complex and acts through a multitude of RNA-RNA, 
RNA-protein and protein-protein interactions. The RNA components of the snRNPs align 
the pre-mRNA splice sites and probably mediate splicing catalysis (Valadkhan and Manley, 
2001). The associated proteins required for splicing mediate the structural rearrangements 
during spliceosome assembly and catalysis of the reaction. They also mediate the 
recognition of the signals present in the pre-mRNA molecule that are necessary for splicing 
(Hastings and Krainer, 2001; Staley and Guthrie, 1998).
The chemical reaction catalysed by the spliceosome consist of two phosphoryl 
transfer reactions (Fig. 1). Even though the spliceosome is an energy-consuming machine, 
no NTP hydrolysis is required for the splicing reaction . In the first step, the 2' hydroxyl of 
a conserved intronic adenosine attacks the phosphate at the 5' splice site, producing a free 5' 
exon and a branched molecule, termed the lariat intermediate. In the second step, the 3' 
hydroxyl group of the 5' exon attacks the phosphate at the 3' splice site, generating the 
ligated mRNA and a lariat intron, which is rapidly degraded (reviewed in Hastings and 
Krainer, 2001).
In order to perform the reactions described above, the spliceosome has to recognise 
the exons and introns in the pre-mRNA molecule. Signals in the pre-mRNA help to direct 
the assembly of the spliceosome for each splicing event. The borders of an intron are 
defined by 5' and 3' splice sites. In mammals, the 5' splice site consensus is AG/GURAGU 
(the / denotes the exon/intron boundary). The 3' splice site is defined by three different 
sequence elements: the branchpoint sequence, YNYURAC, located 18-40 nucleotides 
upstream the 3' splice site; the polypyrimidine tract; and finally the actual 3' splice site 
consensus YAG/N (Burge et al., 1999) (Fig. 2). A splicing error that adds or removes one 
nucleotide will disrupt the open reading frame of an mRNA. Since the sequences that
13
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Figure 1: Two-step chemical mechanism for pre-mRNA splicing. A pre-mRNA with 
a single intron is shown at left, with exons (El, E2) shown as boxes and the intron (IVS) 
shown as a line. The phosphodiester linkages that are broken or formed during the 
reaction are represented by the letter p. The branch adenosine (A) and 2  and 3' hydroxyl 
groups (OH) are also indicated. The ligated exon product and released lariat are shown 
at right. (Taken from Burge et al., 1999)
Pre-mRNA introns
5’ 5 pli ci' silt* branch sîle y sphcc site
(m) ^GURAGU----------------------- UNCU-RAC—(Yn)-
MAJOR
(» G u a u g u ................................ u a c u - a A c .............c a G
AT-AC AUAUCCUU...............  UCCUUAAC....... YCCAC
TRANS G u a a ----------  — u a g u - A A ........u u y a G
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G u g y g ................................................... — A  -A Y
Figure 2: Conserved sequences in nuclear pre-mRNA introns and self-splicing 
group n  introns The 5' and 3' splice-site and branch-site consensus sequences are 
shown (R: purines; Y: pyrimidines). The trans branch-site sequence is from a nematode 
trans-sç)\\Q,\ng substrate. Enlarged letters in each intron indicate highly conserved 
nucleotides. Yn represents a long stretch of pyrimidines that is present in mammalian 
(m) introns; group II and most yeast (y) introns do not contain such a sequence; nematode 
rra«5-splicing substrates usually have a short stretch of pyrimidine residues. Identical 
nucleotides in major-class introns, AT-AC introns, and /raw-splicing introns are shaded. 
(Taken from Yu et al., 1999)
define introns and exons and short and degenerate, the spliceosome faces a major problem 
when it has to find the correct splice sites and splice exons correctly from within tens of 
thousands of intronic nucleotides. Auxiliary c/^-elements, known as splicing enhancers that 
can be either exonic (ESEs) or intronic (ISEs), facilitate the recognition of exons. Exon 
recognition is then accomplished by the accumulated recognition of weak signals. This 
results in a network of interactions across exons as well as across introns (Berget, 1995; 
Reed, 1996), between splicing factors that bind to these weak signals. It is also clear that 
different exons are recognised by different mechanisms and require different sets of 
auxiliary elements in addition to the common splice-site sequences.
The presence of the cap binding complex (CBC) has been shown to increase the 
efficiency with which Ul snRNP binds to the cap-proximal 5' splice site and thus increase 
the rate of recognition and splicing of the cap-proximal intron (Colot et al., 1996; Lewis et 
al., 1996,). In terminal exons, other elements can help the spliceosome to define the 
boundaries. The polyadenylation signal has been shown to promote the use of the last 3' 
splice site (Lewis et al., 1995).
It has been demonstrated that the elongation rate at which RNA pol II transcribes a 
DNA template can influence the efficiency of recognition of a weak splice site by the 
spliceosome (Kadener et al., 2001; Kadener et al., 2002; Nogues et al., 2002). Therefore, 
the kinetics of transcription can also help to define which splice sites have to be used by the 
spliceosome, and this is most relevant in the context of alternative splicing (see section 
1.3).
In lower organisms, including trypanosomatid protozoans, nematodes, trematodes, 
and euglenoids, exons from separately transcribed pre-mRNAs can be spliced by a process 
called trans-s^Xicing (reviewed in Nilsen, 1995). In this process, exons are spliced 
intermolecularly, rather than from within a single precursor RNA as in conventional cis-
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splicing. In this reaction, which is catalysed by another type of spliceosome, the 5' exon is 
supplied by a small RNA termed the splice leader RNA (SL RNA), which has similarities 
to the snRNAs that participate in cw-splicing. In nematodes, the SL RNA interacts with 
specific proteins to form the spliced leader ribonucleoprotein (SL RNP), which is then 
competent to work in trans-spXicmg (Maroney et al., 1990). In addition to the SL RNP, 
other factors including U2, U4/U6, and U5 are also required (Hannon et al., 1991; Maroney 
et al., 1996). Splicing is not only necessary to accurately generate the message that will be 
translated into a protein, but also influences subsequent steps of RNA processing, such as 
mRNA export. A multi-protein complex is deposited on the mRNA in a sequence- 
independent, position-dependent manner, 20-24 nucleotides upstream of mRNA exon-exon 
junctions (EJC, for exon junction complex). The EJC is necessary for recognition of the 
mRNA by the mRNA transport machinery (Le Hir et al., 2000; Luo and Reed, 1999), and 
also plays a role in the fate of the mRNA in the cytoplasm (reviewed by Dreyfuss et al., 
2002).
1.3. Alternative splicing
Alternative splicing is the joining of different 5' and 3' splice sites, allowing the cell 
to increase protein diversity by the generation of multiple, sometimes functionally distinct, 
protein isoforms to be encoded by a single gene. Up to 59% of human genes generate 
multiple RNAs by alternative splicing (Lander et al., 2001), and approximately 80% of 
alternative splicing results in changes in the encoded protein (Modrek and Lee, 2002). This 
is supposed to be a low estimate, since ESTs derive from a limited number of tissues or 
developmental states, and cover only a limited portion of each mRNA. These facts
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postulate alternative splicing as the primary source of human proteomic diversity. There are 
remarkable examples of hundreds or even thousands of functionally different mRNAs or 
proteins produced from a single gene. One of such examples is the Drosophila DSCAM  
gene, which codes for a protein that works as an axon guidance receptor responsible for 
directing growth cones to their proper target in Bolwig's nerve of the fly (Schmucker et al., 
2000). Its pre-mRNA is alternatively spliced and can potentially generate 38016 different 
protein isoforms (reviewed by Graveley, 2001). The Drosophila genome contains 
approximately 13600 identified genes (Adams et al., 2000), whereas a single gene can 
produce nearly as much as three times that number of proteins. These facts postulate 
alternative splicing as the primary source of human proteomic diversity
Alternative splicing occurs when the splicing machinery has the possibility to choose 
from more than one set of splice sites, involving competition among potential splice sites. 
Splice sites that are usually recognised by the spliceosome as weak signals, can be 
positively regulated by trans-a.cûng factors that bind to splicing enhancers. On the other 
hand, strong sites can be negatively regulated by trans-2iC\mg factors, making weak signals 
a better option for the spliceosome (Caceres and Kornblihtt, 2002). The spliceosome can 
face situations in which it can use alternative 5' splice sites, alternative 3' splice sites, 
optional exons, mutually exclusive exons, or it can let an intron be retained in the final 
transcript (Fig. 3). Some alternative splicing events seem to be constitutive, with different 
mRNA isoforms coexisting with a constant relative abundance in the cell, where other 
events are regulated, producing different isoforms in different cell types or at different 
developmental stages.
The specificity seems to be achieved by the relative concentration or activity of 
competing and cooperating factors together with the strength of the splice sites and the 
strength of the binding sites for the trans-dioXmg factors. Regulation is then usually
18
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Figure 3: The alternative splicing patterns that can be used by multiexon-containing 
pre-mRNAs. Boxes represent exons and lines represent introns. Open boxes represent 
the constitutively expressed exons, whereas solid boxes represent the alternatively 
spliced exons. Dash lines represent splicing pathways. In f, the arrows indicate the 
alternative transcription initiation sites, which define the 5’ boundaries of the alternative 
first exons. In g, the arrows indicate the alternative sites of 3' cleavage and polyadenylation, 
which define the 3' boundaries of the alternative last exons. More complex combinations 
of patterns a-g are found in complex transcription units. (Taken from Wang et al., 1997)
accomplished in the early events in the assembly of the spliceosome on the splice sites 
(Smith and Valcarcel, 2000). Nevertheless, there are examples of spliceosomal proteins, 
like SPF45, that interact with the AG at the 3' splice site and can activate alternative 3' 
splice sites during the second step of splicing (Lallena et al., 2002).
1.4. The spliceosome
The spliceosome consists of the five small nuclear ribonucleoprotein particles 
(snRNPs) U l, U2, U4, U5 and U6, and 50-100 non-snRNP splicing factors (Kramer, 1996). 
Each snRNP particle consists of a multi-subunit complex between an uracyl-rich small 
nuclear RNA (U snRNA) and several proteins, some of which are unique to the individual 
snRNP and others that are common to many spliceosomal snRNPs (Sm or Sm-like 
proteins) (Will and Luhrmann 2001).
The spliceosomal snRNPs are very abundant, with over a million copies per cell. 
These snRNPs are part of the major spliceosome, that is responsible for splicing the vast 
majority of pre-mRNA introns (so-called U2-type introns). There is also a set of less 
abundant snRNPs, Ul 1, U12, U4atac and U6atac, that together with U5, are subunits of the 
so-called minor spliceosome that splices a rare class of pre-mRNA introns, denoted U 12- 
type (reviewed by Burge et al., 1999). The consensus sequences recognised by the minor 
spliceosome are different from those recognised by the major spliceosome, and are more 
strongly conserved than those of U2-type introns. The minor spliceosome splices introns 
containing either /ATATCCTTT and YAC/ or /GTATCCTTT and Y AG/, respectively 
(where / represents the splice junction). For both the AT-AC and GT-AG subtypes of this 
rare intro class, the conserved branch site signal follows the consensus TCCTTAAC
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(branch site underlined). The proportion of U 12-type introns is very small, about one in a 
thousand.
U snRNP biogenesis is a complex process (for a review see Will and Luhrmann, 
1997). With the exception of U6, all the spliceosomal snRNAs are transcribed by RNA pol 
II as snRNA precursors that contain additional 3' nucleotides and acquire a 
monomethylated, m7GpppG (m7G) cap structure. Then, these pre-U snRNAs are exported 
to the cytoplasm, where they interact in an ordered, stepwise manner with seven Sm 
proteins, B/B', D3, D2, D l, E, F, and G, to form the snRNP Sm core structure. 
Subsequently, the m7G cap is converted to the 2,2,7-tri-methylated guanosine (m3G), and 
U snRNAs undergo 3' end maturation. After processing in the cytoplasm, U snRNP are re­
imported to the nucleus, where they assemble with their individually specific snRNP 
proteins. Although less is known about the maturation process of the minor Ul 1, U12 and 
U4 atac snRNPs, it is assumed that they follow a pathway similar to that described for the 
major spliceosome snRNPs. Biogenesis of U6 snRNP, and presumably U6atac snRNP, 
differs in many ways from the one described for the other spliceosomal snRNPs. The U6 
snRNA is transcribed by RNA pol III and the processing occurs entirely in the nucleus. The 
U6 snRNA acquires a y-monomethyl cap structure and is also internally modified primarily 
by pseudouridylation and 2'-0-methylation. The U6 snRNA assembles with Sm-like 
proteins. Finally, the mature U6 snRNP particle pairs to U4 snRNP to form the U4AJ6 
snRNP.
The spliceosome assembles in a stepwise fashion (Fig. 4) (for a review see Staley and 
Guthrie, 1998). The commitment of pre-mRNA to the splicing pathway occurs upon ATP- 
independent formation of the E (early) complex. Assembly of the E complex involves 
recognition of the 5' splice site by Ul snRNP base pairing, binding of SFl/mBBP (splicing 
factor 1/ mammalian branch point binding protein) to the branchpoint sequence and
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Figure 4: Spliceosome assembly pathway. See text for description. 
(Taken from Graveley, 2000)
association of the U2 auxiliary factor (U2AF), which binds to the polypyrimidine tract and 
the AG at the 3' splice site. Next, U2 snRNP base pairs with the branchpoint sequence 
during the ATP-dependent formation of the A-complex. The subsequent association of the 
U4/U6-U5 tri-snRNP with the pre-mRNA results in the formation of the B complex, and 
finally, the C complex is formed by rearrangements of RNA-RNA, RNA-protein and 
protein-protein interactions to create the catalytically competent spliceosome. Members of 
the serine and arginine-rich proteins (SR proteins) function as molecular adapters, 
mediating interactions between the pre-mRNA and the assembling spliceosome throughout 
the whole pathway. Their function and characteristics will be discussed later in this chapter.
The recognition of the 5' splice site by Ul snRNP involves base pairing between the 
5' splice site and 10 strongly conserved nucleotides at the 5' end of U l snRNA; these are 
highly complementary sequences (Séraphin et al., 1988; Siliciano and Guthrie, 1988; 
Zhuang and Weiner, 1986). In the absence of base pairing, the Ul snRNP U lC  protein 
recognises the 5' splice site (Du and Rosbash, 2002). Although the presence of U l snRNP 
is necessary for splicing in vitro, increasing amounts of SR proteins can restore splicing in 
nuclear extracts depleted of U l snRNP by antisense affinity depletion (Crispino et al., 
1994; Tarn and Steitz, 1994). In this case, the 5' splice site is recognised by U6 snRNP 
(Crispino and Sharp, 1995). The binding of Ul snRNP is destabilised when the U4/U6-U5 
tri-snRNP particle is added to the spliceosome, followed by several rearrangements in 
which U l is replaced by U5 and U6 at the 5' splice site (Kandels-Lewis and Séraphin, 
1993).
U2 snRNP associates with the E complex in an ATP-independent manner that does 
not require the branch point sequence, but its stable binding to the branch point sequence 
requires ATP and several proteins (Das et al., 2000). U2AF, an essential splicing factor 
purified as a heterodimer composed of 65 kDa (U2AF^^) and 35 kDa (U2AF^^) subunits,
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facilitates U2 snRNP binding to the pre-mRNA (Zamore and Green, 1989). U2AF^^ binds 
directly to the polypyrimidine tract, whereas U2AF^^ binds to the AG at the 3' splice site 
(Merendino et al., 1999; Wu et al., 1999; Zorio and Blumenthal, 1999). Several studies 
support a mechanism whereby SR proteins bound to splicing enhancers interact with 
U2AF^^, thereby recruiting U2AF^^ to a weak 3' splice site (reviewed in Graveley, 2000). 
SFl/mBBP cooperatively binds to U2AF^^ to promote the binding of U2 snRNP to the 
branchpoint sequence (Berglund et al., 1998), a process that involves other proteins as 
UAP56, p54 and SAP155 (Fleckner et al., 1997; Gozani et al., 1998; Zhang and Wu, 1996). 
Other proteins that are also required for stable binding of U2 snRNP to the branch point 
sequence are SF3a and SF3b, which comprise multiple subunits (Brosi et al., 1993a; Brosi 
et al., 1993b). The SF3b protein subunit p i4, cross-links to the branch point adenosine after 
the incorporation of the U2 snRNP into the spliceosome, and it can be cross-linked in 
subsequently formed complexes, including the catalytically active spliceosomal C complex 
(MacMillan et al., 1994; Query et al., 1996).
Upon the joining of the U4/U6-U5 tri-snRNP, several rearrangements of RNA-RNA 
interactions take place to form the active spliceosome. U5 snRNP makes contact with the 5' 
and 3' ends of the intron. This interaction brings the two splice sites together. A U5 snRNP- 
speciftc protein, Prp8 (U5-220 kDa, p220 or hPrp8) is closely associated with the 
sequences at the 5' splice site, branch site, and 3' splice site, implying a function as a major 
scaffolding protein for aligning the splice sites. U6 snRNP dissociates from U4 snRNP and 
interacts with U2 snRNP. Upon interaction with U2 snRNP, U6 snRNP displaces U1 
snRNP and remains bound to the 5' splice site of the intron (Murray and Jarrell, 1999), and 
this change positions the branch site adenosine for attack at the 5' splice site (Madhani and 
Guthrie, 1994). The lariat-exon intermediate and the free 5' exon are formed during the first 
catalytic step of splicing. Before the second step of splicing, additional rearrangements
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occur, creating new RNA-RNA interactions. The U2-U6 snRNP interaction changes and 
contacts the 5' splice site in the lariat intermediate and the free 5' exon is joined together 
with the 3' exon (Burge et al., 1999). Several DExD/H box ATPases are believed to 
function as motors that drive the RNA rearrangements during splicing (Staley and Guthrie, 
1998^
This idea of an order of addition of discrete U l, U2, and U4/U6-U5 snRNPs to the 
pre-mRNA substrate during spliceosome assembly has been challenged by the recent 
discovery in yeast extracts of a very large particle containing all five of the U snRNPs. The 
existence of this penta-snRNP particle suggests that the spliceosome may actually exist as a 
pre-assembled multi-snRNP particle, independently of a pre-mRNA substrate (reviewed in 
Nilsen, 2002; Stevens et al., 2002).
1.5. SR proteins
The SR proteins are a highly conserved family of essential pre-mRNA splicing 
factors (for reviews see Fu, 1995; Graveley, 2000; Manley and Tacke, 1996). They are 
required for constitutive splicing as well as for the regulation of alternative splicing. SR 
proteins have a modular domain structure consisting of one or two copies of an N-terminal 
RNA recognition motif (RRM, also known as RBD, for RNA-binding domain) and a C- 
terminal domain rich in alternating serine and arginine residues, known as RS domain (Fig. 
5). The RRMs determine the specificity in binding to RNA, while the RS domain 
participates in protein-protein interactions.
SR proteins were independently discovered by a number of groups taking very 
different approaches. The prototypical SR protein, SF2/ASF (splicing factor 2/altemative
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Figure 5: Schematic diagram of human SR proteins. The domain structures of the 
known members of the human SR protein family are depicted. RRM; RNA recognition 
motif; RRMH: RRM homology; Z: zinc knuckle; RS: arginine/serine-rich domain. 
(Taken from Graveley, 2000)
splicing factor, also referred to as ASF/SF2), was discovered and characterised 
independently by two different groups employing two different assays. ASF was purified as 
an activity that could regulate the selection of alternative 5' splice sites (Ge and Manley,
1990), suggesting a role for ASF in alternative splicing. On the other hand, SF2 was 
identified initially as an activity required for splicing of a p-globin pre-mRNA in vitro 
(Krainer and Maniatis, 1985) and was subsequently purified as a factor essential for 
splicing (Krainer et al., 1990b), but with the ability to modulate alternative splicing in vitro, 
in a concentration-dependent manner (Krainer et al., 1990a). Posterior isolation of cDNAs 
encoding the proteins confirmed that they were identieal (Ge et al., 1991; Krainer et al.,
1991). SC35 was identified with a monoelonal antibody raised against purified 
spliceosomes and was shown to be necessary for splicing and spliceosome assembly in 
vitro (Fu and Maniatis, 1990; Fu and Maniatis, 1992). Most other SR proteins were 
identified based on their reactivity with a monoclonal antibody, mAbl04, that recognises a 
phosphorylated epitope and reacts against active sites of RNA pol II transcription on 
lampbrush amphibian chromosomes (Roth et al., 1991). All the proteins recognised by 
mAbl04 could be easily purified by a simple two-step purification involving selective 
precipitation in the presence of millimolar eoncentrations of MgCb (Zahler et al., 1992). By 
following this two-step protocol it is possible to obtain homogeneous preparations 
consisting of six major proteins ranging in apparent size from 20 to 75 kDa. Proteins of 
similar sizes could be purified from different speeies, suggesting that the protein family is 
evolutionary well conserved from Drosophila to humans. Partial amino acid sequence 
revealed that all the proteins shared sequenee similarity, and those of approximately 30 kDa 
were found to be identical to SF2/ASF and SC35. The purified proteins also all have the 
ability to function as essential splicing factors. Roth and colleagues (Zahler et al., 1992) 
proposed five criteria that define the family of SR proteins: (1) They contain a shared
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phosphoepitope recognised by the monoclonal antibody mAbl04. (2) They copurify in a 
two-step salt precipitation procedure (soluble in 65% ammonium sulfate and precipitated in 
20 mM MgCh). (3) They share a similar protein structure containing at least one RRM at 
the N-terminus and an RS domain at the C-terminus. (4) Their sizes on SDS-PAGE are 
conserved from Drosophila to man. (5) They can complement splicing deficient S I00 
extracts. Degenerate primers matching conserved features in the RNP-2 and RNP-1 
submotifs of RRM l, or the eonserved heptapeptide present in RRM2 allowed the 
identification and cloning of more members of the family (Kim and Baker, 1993; Kim et 
al., 1992; Screaton et al., 1995). One of the proteins identified by this method, SRp30c, 
does not fully comply with the requirements proposed by Roth and colleagues to be 
assigned to the family, since it was not detected after purification with the two-step 
protocol, probably due to low abundance. Another member of the family, p54, was isolated 
by expression cloning using an anti-lamin B autoantiserum and is similar in size and 
structure to SRp75 (Chaudhary et al., 1991). Although the protein is less homologous to the 
canonical SR proteins, it has been shown to be reactive to mAbl04 and to be capable of 
complementing S I00 extracts (Zhang and Wu, 1996). Finally, the nuclear antigen 9G8 was 
identified by a monoclonal antibody raised against heterogeneous nuclear 
ribonucleoproteins (hnRNPs) (Cavaloe et al., 1994). Again, this protein does not fully 
comply with the definition of SR proteins, since it is recognised weakly by mAbl04 and 
besides the N-terminal RRM and the C-terminal RS domain, it also contains a zinc finger 
motif. However, 9G8 is commonly considered as a member of the SR family. Although SR 
proteins have been identified in all metazoans examined and in plants, they are not present 
in all eukaryotes. Whereas two SR proteins have been identified in the fission yeast 
Schizosaccharomycespomhe (Gross et al., 1998; Lutzelberger et al., 1999), none has been 
found in Saccharomyces cerevisiae.
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Additionally, there is a growing number of RS-containing proteins that are 
structurally very similar to bona fide SR proteins although they do not share all common 
functions. For example, SRrp86, a protein that contains a single RRM in its amino terminus 
and two carboxy-terminal RS domains separated by an unusual glutamic acid-lysine (EK)- 
rich region, is unable to complement splicing-deficient S I00 extracts. Actually, SRrp86 
inhibits the activity of bona fide SR proteins, such as SC35 or SF2/ASF, in an S I00 
complementation assay (Barnard and Patton, 2000). Likewise, SRrp30 and SRrp40 contain 
a single RRM and an RS domain, but are unable to eomplement S I00 extracts and 
antagonise SR proteins in in vitro splieing assays (Cowper et al., 2001). In another report 
(Shin and Manley, 2002) SRrp40 (also called SRp38) was shown to repress general 
splicing in mitotic extracts (Shin and Manley, 2002).
The proteins described above belong to a group of proteins that are colleetively 
known as SR protein related polypeptides (SRrp) or SR-related proteins. The only common 
feature of members of this group is the presence of an RS domain. SR-related proteins have 
diverse functions in the processing of pre-mRNA. A detailed description of the members of 
this group will be given later in this chapter (see section 1.8).
The SR proteins seem to be functionally redundant in constitutive splicing as 
illustrated by the ability of any individual SR protein to complement an otherwise inactive 
cytosolic HeLa SI 00 extract. However, several differences in the ability of these proteins to 
regulate alternative splicing, as well as the ability of individual SR proteins to commit 
different pre-mRNAs to the splicing pathway suggested that individual SR proteins may 
have unique functions in splicing regulation (reviewed in Sanford et al., 2003). Genetic 
approaches used to address this question showed that deletion of the gene encoding the B52 
protein (ortholog of human SRp55) in Drosophila melanogaster results in lethality (Peng 
and Mount, 1995; Ring and Lis, 1994). Likewise, eonditional depletion of SF2/ASF in
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chicken DT40 cell line results in cell death (Wang et ah, 1996). Interestingly, knockout of 
the SRp20 gene in the mouse blocked development at a very early stage (Jumaa et al., 
1999). Additionally, Cre-mediated conditional deletion of SC35 in the thymus causes a 
defect in T cell maturation (Wang et al., 2001). These observations gave rise to the general 
impression that SR proteins are required for cell viability. However, when the expression of 
the genes encoding different SR proteins were ablated individually by RNA interference 
(RNAi) in Caenorhabditis elegans, no phenotype was observed for all the cases, except for 
the SF2/ASF ortholog, rsp-3 (Longman et al., 2000). But when multiple C. elegans SR 
protein genes were simultaneously targeted by this method, developmental defects or 
lethality were observed (Longman et al., 2000). The basis for these results is still unknown. 
Either the nonessential SR proteins do simply not participate in the splicing of essential 
genes, or the other SR proteins present in the cell can functionally substitute for the missing 
one. In the case of the B52 knock-out in Drosophila, no general splieing defects were found 
in the null background, either for constitutive or alternatively spliced genes (Ring and Lis,
1994); however recent observations suggest that the lethality of the B52 deletion strain is a 
consequence of splicing defects in tissues in which B52 is normally the major SR protein 
(Hoffman and Lis, 2000).
1.6. The RNA recognition motif
The RNA recognition motif (RRM) is a conserved, modular domain of approximately 
80 amino acids that contains two small, highly conserved sequence elements, the RNP-1 
octamer and the RNP-2 hexamer (Hoffman et al., 1991; Nagai et al., 1990). The RRM 
motif is present in a variable number of copies in several RNA-binding proteins involved in
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pre-mRNA and pre-rRNA processing (Bimey et al., 1993; Kenan et al., 1991). Substitution 
of conserved residues within the RNP-1 and RNP-2 submotifs affects binding of the UlA  
and U1-70K proteins to Ul snRNA (Scherly et al., 1989; Surowy et al., 1989). SR proteins 
contain either one or two RRMs. In those containing two RRMs, the second RRM is 
atypical, not highly conserved, and always contains the heptapeptide, SWQDLKD (Bimey 
et al., 1993). Mutations in the RNP motifs of SF2/ASF inhibits binding of the protein to 
RNA, resulting in a decreased activity of the protein in pre-mRNA splicing (Caceres and 
Krainer, 1993). The RRMs of SR proteins bind RNA in a sequence-specific manner, even 
in the absence of the RS domain (Manley and Tacke, 1996). SELEX protocols (selected 
evolution of ligands through exponential enrichment) have been employed to eharacterise 
the RNA binding specificity of individual SR proteins (Adams et al., 2000; Cavaloe et al., 
1999; Liu et al., 1998; Schaal and Maniatis, 1999b; Tacke et al., 1997; Tacke and Manley,
1995). These studies led to the conclusion that SR proteins recognise a vast array of 
sequences (for a review, see Tacke and Manley, 1999). Although SR proteins do display 
distinet RNA binding specificities, the consensus sequences they recognise are rather 
degenerate.
The RRMs of SR proteins have also been suggested to mediate protein-protein 
interactions. Using chimeric proteins consisting of domain swaps between different SR 
proteins, it was shown that the specificity displayed by SR proteins in alternative splicing is 
determined by the RRMs (van Der Houven Van Oordt et al., 2000). In this study, the 
RRM2 of SF2/ASF was shown to have a dominant role in alternative splicing. One possible 
explanation for the dominant role of this domain in alternative splicing could lie in the 
establishment of new protein-protein interaetions. In this scenario, the RRM2 of SF2/ASF 
could help to recruit additional splicing factors to the spliceosome and modulate splicing 
specificity. The RRM2 of SF2/ASF was also shown to be both necessary and sufficient to
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repress splicing of the adenovirus Ilia pre-mRNA. (Dauksaite and Akusjarvi, 2002). The 
heptapeptide SWQDLKD, which is unlikely to be directly involved in RNA binding given 
its position in the predicted structure of RRM2, was essential for splicing repression. This 
observation suggested that the repressive activity shown by the RRM2 of SF2/ASF is 
achieved by directly interacting with either proteins that are required for early splice site 
recognition or that negatively affect splice site recognition.
1.7. The RS domain
The RS domain was originally identified in the Drosophila splicing regulators Tra, 
Tra2 and suppressor-of-white-apricot (SWAP). Subsequently, RS domains were also found 
in the Ul snRNP- specific, U l 70K protein, and in members of the SR protein family. The 
RS domain consists of simple arginine and serine repeats, that can be occasionally 
interrupted by other amino acids, and the length and sequence of RS domains are usually 
conserved among species.
The RS domain of SR proteins mediates protein-protein interactions with other RS
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domain containing factors such as U1-70K and U2AF (Amrein et al., 1994; Kohtz et al., 
1994; Wu and Maniatis, 1993). However, not all RS-domain containing proteins can 
interact with one another, suggesting that different protein-protein interactions may have 
different RS domain sequence requirements. For example, SF2/ASF and SC35 internet with 
U1-70K and U2AF^^ (Wu and Maniatis, 1993), but p54 is unable to do so (Zhang and Wu,
1996). Moreover, SF2/ASF is able to interact with U1-70K, but its RS domain alone is not 
sufficient for this interaction. In contrast, the RS domain of SF2/ASF on its own is able to 
internet with RSFl, a Drosophila splicing repressor (Labourier et al., 1999).
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specific roles for the RS domains of individual SR proteins were suggested by the 
high phylogenetic conservation of specific sequences within the RS domains (Bimey et ah, 
1993). Chimeric proteins containing different RS domains fused to the RRM of the 
bacteriophage MS2 protein aetivated splicing of substrates containing a single MS2 binding 
site, and this activation correlated directly with the number of RS dipeptides present in the 
RS domain, suggesting that different RS domains have unique activities (Graveley and 
Maniatis, 1998). Moreover, individual RS domains have unique properties in direeting 
subcellular localization and influencing the ability of SR proteins to shuttle from the 
nucleus to the cytoplasm (Sanford et al., 2003) . However, in other experimental systems, 
the RS domain of SR proteins seem to be functionally redundant. For instance, the RS 
domains of SF2/ASF and SC35 are functionally interchangeable in S I00 complementation 
assays (Mayeda et al., 1999b). Interestingly, the RS domains are also functionally 
interchangeable in vivo, as shown by the ability of chimeric proteins consisting of the 
RRMs of SF2/ASF fused to RS domains of different SR proteins to rescue cell viability in a 
chicken B cell line DT40 (Wang et al., 1998). In contrast, it was recently shown that RS 
domains are not all functionally equivalent in vivo in Drosophila as different RS domains 
varied considerably in their ability to restore Tra2 function (Dauwalder and Mattox, 1998).
RS-domain containing proteins are generally widely distributed throughout the 
nucleus, exeluding nucleoli, and are highly concentrated in subnuclear structures referred to 
as nuclear speckles, which correspond to the interchromatin granule clusters and associated 
perichromatin fibrils observed by electron microscopy (reviewed in Speetor et al., 1993). 
There are about 20-40 speckle structures per nucleus, and they occupy ~20% of total 
nuclear volume. It has been proposed that the function of these speckles is the storage 
and/or assembly of spliceosomal components (Misteli, 2000). In addition, to pre-mRNA 
splicing factors and snRNAs, speckles also contain transcription factors (Zeng et al., 1997),
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3'-processing factors (Schul et al., 1998), and ribosomal proteins (Mintz et al., 1999). 
Biochemical purification of these nuclear structures indicate that they contain about 150 
proteins, although it remains to be determined which ones are bona fide residents (Mintz et 
al., 1999).
The subcellular localisation of SR proteins is influenced by the RS domain, which 
mediates the interaction with the SR protein nuclear import receptor, transportin-SR 
(Kataoka et al., 1999; Lai et al., 2000; Lai et al., 2001; Yun et al., 2003). Although the RS 
domain is a nuelear localisation signal, subnuclear targeting to the speckles requires at least 
two of the three constituent domains of SF2/ASF. In contrast, in two SR proteins that have 
a single RRM (SC35 and SRp20), the RS domain is both necessary and sufficient as a 
targeting signal to the speckles (Caceres et al., 1997; Hedley et al., 1995; Li and Bingham, 
1991). The RS domain is also an important determinant of nucleo-cytoplasmic shuttling; 
however, this domain is not suffieient to promote shuttling of an unrelated protein reporter, 
suggesting that additional signals are required (Caceres et al., 1998).
1.8. SR protein phosphorylation
Whereas phosphorylated SR proteins are required for the assembly o f the 
spliceosome (Mermoud et al., 1994), déphosphorylation of SR proteins is required for 
splicing catalysis (Xiao and Manley, 1998). The SR proteins domains are extensively 
modified by phosphorylation, mainly at the serine residues in the RS domain (Colwill et al., 
1996b). Several kinases have been shown to phosphorylate RS domains. These include 
SRPKl (Gui et al., 1994) and SRPK2 (Wang et al., 1998), the Clk-Sty family (Colwill et 
al., 1996a), DNA topoisomerase I (Rossi et al., 1996) and cdc2 (Okamoto et al., 1998).
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DO A, an homologue of Clk/Sty in D. melanogaster, was shown to phosphorylate RBPl, 
Tra and Tra2 in vitro and RBPl in vivo (Du et al., 1998) and to regulate the splicing of dsx 
pre-mRNA (Du et al., 1998). The phosphorylation of the RS domain appears to influence 
the subcellular localisation of SR proteins. Addition of purified SRPKl to permeabilised 
cells, or overexpression of SRPKl, 2 or cdc2-like kinase (Clk)l in transfected cells result in 
apparent disassembly of the nuclear speckles (Colwill et al., 1996a; Duncan et al., 1998; 
Gui et al., 1994; Kuroyanagi et al., 1998; Wang et al., 1998). These results suggest that 
phosphorylation, or hyperphosphorylation, causes release of these faetors from the 
speckles, or perhaps that the integrity of these structures is compromised. Phosphorylation 
also causes redistribution of SR proteins from speckles to sites of transeription (Misteli et 
al., 1998). The phosphorylation of RS domains modifies their ability to interact with each 
other and with U1-70K (Wang et al., 1998; Xiao and Manley, 1998), and influences their 
ability to bind RNA (Tacke et al., 1997; Xiao and Manley, 1997). Sinee the state of 
phosphorylation of the RS domain of SR proteins affect their ability to interact with both 
proteins and RNA, it is expected that the state of phosphorylation of their RS domains 
would affect their activities in splicing. In fact, both phosphorylation and 
dephosphorylation of SR protein are necessary for splicing in vitro (Cao et al., 1997; Xiao 
and Manley, 1997; Xiao and Manley, 1998). Different steps in splicing require different 
extent of phosphorylation of the RS domain.
The level of phosphorylation of SR proteins also affect their activity in alternative 
splicing. SR proteins are highly phosphorylated in vivo, a modification that is required for 
inhibition the splicing of adenovirus Ilia pre-mRNA. It was shown that SR proteins 
purified from late adenovirus-infected eells are inactivated as splicing repressor proteins by 
virus-induced dephosphorylation (Kanopka et al., 1998). SR proteins are dephosphorylated 
by the endogenous protein phosphatase 2A, which is activated by the viral protein E4-
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0RF4. E4-ORF4 binds directly to SF2/ASF, and this interaction seems to be necessary for 
relieving the repressive effect of SR proteins on Ilia pre-mRNA splicing in transient 
transfection experiments (Estmer Nilsson et al., 2001).
1.9. Functions of SR proteins
Roles in splicing
SR proteins show a great flexibility that allows them to function at numerous steps in 
spliceosome assembly and to regulate splice site selection (Fu, 1995; Graveley, 2000). The 
roles of SR proteins in splicing can be divided into two big categories: exon-dependent and 
exon-independent functions (Fig. 6) (Graveley, 2000).
Exon-dependent functions
In order to perform the exon dependent functions, SR proteins must bind to ESEs. 
Several papers showed that SR proteins could bind to ESEs to enhance the splicing of 
adjacent introns. For example, SR family proteins bound to ESEs can promote U2AF 
recruitment to the polypyrimidine tract and activate an adjacent 3' splice site (Graveley et 
al., 2001; Romfo et al., 2001). This activity involves the interaction between the RS domain 
of the ESE bound SR protein and the RS domain of U2AF^^ (recruitment model) (Zuo and 
Maniatis, 1996). But not all the cases of enhaneer-dependent splice site selection can be 
explained by the recruitment model. In certain pre-mRNA substrates, the presence of ESE- 
bound SR proteins do not enhance the binding of U2AF to the polypyrimidine tract but 
rather helps to antagonise the activity of proteins bound to ESSs (Hastings and Krainer,
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Figure 6: SR proteins are involved at numerous steps of pre-spliceosome assembly.
(A) The organisation of splicing signals within a typical pre-mRNA. Exons (open boxes) 
may contain splicing enhancer elements (wavy boxes) that promote recognition of the 
nearby 5' or 3' splice sites (GU and AG, respectively). Additional signals consist of the 
polypyrimidine tract (Y) that resides between the branch point adenosine (A) and the 
3' splice site. (B) The exon-dependent and -independent functions of SR proteins in 
pre-spliceosome assembly. SR proteins can promote both the recognition of 5' and 3’ 
splice site as well as communication of splice sites by exon definition or intron bridging 
interactions. Arrows indicate RS domain-mediated interactions. (Taken from Sanford 
et al., 2003)
2001). One example that illustrates this mechanism is the HIV-1 tat exonS, which contains 
ESEs that are bound by SF2/ASF and SC35 and also contains an ESS that is recognised by 
hnRNPAl. Initial binding of hnRNPAl to the ESS promotes further binding of hnRNPAl 
upstream in the exon, preventing the binding of SC35 to the ESE, but not the binding of 
SF2/ASF. Therefore, the ESS suppressed SC35 but SF2/ASF-dependent splicing (Zhu et 
al., 2001). Besides promoting the use of alternative 3' splice sites, SR proteins ean bind to 
exonic enhancers to promote the recognition of alternative 5' splice sites. Alternative 
splicing of the fruitless gene in Drosophila (fru) is regulated by Tra and Tra2 and depends 
on an exonic splicing enhancer (fruRE) consisting of three 13-nucleotide repeat elements, 
nearly identical to those that regulate alternative sex-specific 3'-splice site choice in the 
doublesex (dsx) gene (Lynch and Maniatis, 1996, Lam, 2003). The Tra, Tra2 and RBPl 
(Drosophila homologue of SRp20) complex was directly implicated in the selection of this 
5' splice site in fruitless pre-mRNA (Ryner et al., 1996), suggesting that SR proteins bound 
to upstream splicing enhancers can stimulate the binding of Ul snRNP to the downstream 
splice site through an interaction with U1-70K, an SR-related protein that is a stable 
eomponent of Ul snRNP. In constitutive splicing, SR proteins are believed to participate 
in the definition of exons (Berget, 1995) by binding to the exon where they simultaneously 
interact with U2AF^^ at the 3' splice site and U1-70K in the 5' splice site. Some authors 
hypothesise that the majority of the constitutively spliced exons are recognised by this 
mechanism (Reed, 1996). In support of this model, SR protein binding sites are found in 
constitutive exons and some have been shown to aet as constitutive splicing enhancers 
(Mayeda et al., 1999b; Schaal and Maniatis, 1999a). SR proteins can also negatively 
regulate the splicing of an intron by binding to an ESS. One example that illustrates this 
meehanism of regulation is a late mRNA in bovine papilloma virus 1 (BPV-1), that 
contains an array of two ESEs and an ESS between them. All three elements bind SR
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proteins, and the SR proteins bound to the ESS are believed to sequester SR proteins bound 
to ESEs or to interfere with the bridging activities of the SR proteins bound to ESEs (Zheng 
et ah, 1998). The context of the binding element is important in defining the aetivity of the 
SR protein bound to it. SF2/ASF inhibits adenovirus Ilia pre-mRNA splicing by binding to 
an intronic repressor element, but activates splicing of the same pre-mRNA when the 
repressor element is situated in an exon (Kanopka et al., 1996).
Exon-independent functions
The exon independent functions of SR proteins are those for which a requirement for 
binding to an exonic sequence has not been determined. For instance, SR proteins 
interacting with U1-70K and U2AF^^ act as a bridge between components bound to the 5' 
and 3' splice sites (Kohtz et al., 1994; Wu and Maniatis, 1993). SR proteins are also 
required for trans-spXicmg, in which the 5' and the 3' splice sites are contained in different 
molecules (Bruzik and Maniatis, 1995; Chiara and Reed, 1995). SR proteins also facilitate 
the recruitment of the U4/U6-U5 tri-snRNP to the pre-spliceosome (Cao et al., 1997; Fetzer 
et al., 1997; Tam and Steitz, 1995; Teigelkamp et al., 1997). This reeruitment may involve 
the interaction of SR proteins with SR-related proteins associated with the U4/U6-U5 tri- 
snRNP, such as the tri-snRNP associated proteins of 27kDa (Fetzer et al., 1997), of 65 and 
110 kDa (Makarova et al., 2001), or the U5-100K associated protein (Teigelkamp et al., 
1997). As mentioned earlier in this chapter (section 1.4.), SR proteins can restore splicing 
in extracts depleted from Ul snRNP (Crispino et al., 1994; Tarn and Steitz, 1994). The SR 
protein SF2/ASF can antagonise the effect of hnRNP A/B type proteins on the selection of 
alternative 5' splice sites in a concentration-dependent manner (Caceres et al., 1994; 
Mayeda et al., 1993; Mayeda and Krainer, 1992; Wang and Manley, 1995). SF2/ASF was
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shown to do this by enhancing the binding of Ul snRNP to all the 5' splice sites, resulting 
in the selection of the 5' proximal splice site. On the contrary, hnRNP A1 binds co­
operatively and indiscriminately to the pre-mRNA and interferes with the binding of Ul 
snRNP, resulting in the selection of the distal 5' splice site (Eperon et al., 1993; Eperon et 
al., 2000).
Other functions of SR proteins
When an mRNA is synthesized in the nucleus, it is immediately coated with a group of 
proteins, the hnRNPs. These proteins participate in a wide variety of processes in the 
nucleus (reviewed in Krecic and Swanson, 1999), and in the cytoplasm (reviewed in Shyu 
and Wilkinson, 2000). The cytoplasmic functions of hnRNPs include the regulation of 
cytoplasmic mRNA localisation, translation and mRNA turnover. It has been observed that, 
like the hnRNPs, a subset of SR family proteins including SF2/ASF, SRp20, 9G8, but not 
SC35 and SRp40, shuttle between that nucleus and the cytoplasm (Caceres et al., 1998). 
This observation suggested that, like hnRNPs, SR proteins could have functions in post­
splicing mRNA processing, as well as functions in the cytoplasm. Recently, reports from 
the Steitz laboratory have confirmed this hypothesis. Using UV-crosslinking, transient 
transfections and Xenopus oocyte microinjection, it was shown that the shuttling proteins 
SRp20 and 9G8 interact specifically with a 22-nt RNA element from the histone H2a gene 
to promote the export of intronless RNAs in both mammalian cells and Xenopus oocytes 
(Huang and Steitz, 2001). More recently, these SR proteins and also SF2/ASF were shown 
to interact directly to the major receptor for bulk mRNA export to the cytoplasm, 
TAP/NXFl (Huang et al., 2003), suggesting a role for SR proteins as adapters in mRNA
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export. Probably in the years to come other roles of SR proteins in the cytoplasm will be 
reported.
1.10. SR-related proteins
The SR-related proteins comprise a group of proteins containing an RS domain that 
have a distinct domain structure from the SR family of proteins (described in seetions 1.5. 
and 1.8.). A genome-wide survey (Boucher et al., 2001) revealed a large complexity of RS 
domain-containing proteins in metazoans with functions not only in RNA processing, but 
also in chromatin structure, transcription by RNA pol II, cell cycle and cell structure 
(Boucher et al., 2001). This study also identified six RS-domain-containing proteins in S. 
cerevisiae with functions associated with cell structure, osmotic regulation and cell cycle 
progression. Interestingly, the vast majority of the RS related proteins identified are either 
known nuclear proteins, or related to nuclear-localised proteins. This is consistent with 
previous evidence indicating a role for RS domains in the nuclear-targeting of proteins (see 
seetion 1.7.). Most of the metazoan proteins analysed were linked to the transcription or 
processing of RNA pol II transcripts, but none of the proteins were known to be associated 
with the generation of either RNA pol I or pol III transcripts.
SR-related proteins and spacing
Most of the SR-related proteins with a known function are involved in pre-mRNA 
splicing (Fig. 7). Unlike SR proteins, the majority of them do not contain RRMs and are not 
able to complement splicing deficient SI 00 extracts. One of the best characterised
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B. Human SR Related Proteins 
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Figure 7: Schematic diagram of SR-related proteins. The domain structures for some 
of the human SR-related proteins that participate in pre-mRNA splicing are depicted. 
All proteins, with the exception of SRmSOO, are drawn to scale. RRM: RNA recognition 
motif; RS: argenine/serine-rich domain; Zn: zinc finger: DEXD/H Box: motif characteristic 
of RNA helicases. (Taken from Graveley, 2000)
examples are the subunits of the U2AF splicing factor, U2AF^^ and U2AF^^. The largest 
subunit, U2AF^^, contains three RRMs responsible for binding to the polypyrimidine tract 
(Zamore et ah, 1992) and an N-terminal RS domain, that faeilitates the binding of the U2 
snRNP to the branch point (Valcarcel et ah, 1996). In contrast, U2AF^^, which contains an 
atypical N-terminal RRM followed by an RS domain, contaets the AG at the 3’ splice site 
(Merendino et ah, 1999; Wu et ah, 1999; Zorio and Blumenthal, 1999) and stabilises the 
binding of U2AF^^ to the polypyrimidine tract (Zuo and Maniatis, 1996). An U2AF^^-like 
factor, HCCl, was identified using an autoantiserum from a hepatocellular carcinoma 
patient (Imai et ah, 1993). HCCl co-localises with other splicing factors in nuclear speckles 
and is very similar in size and structure to U2AF^^; however, its role in splicing remains to 
be established. A protein related to the splicing factor U2AF^^, Urp (for U2AF^^ related 
protein), was identified in a two-hybrid screen using an SR kinase (SRPKl) as a bait. Urp 
specifically interacts with U2AF^^ through a U2AF^^-homologous region and with 
SF2/ASF and SC35 through its RS domain. Therefore, Urp and U2AF^^ may independently 
position RS-domain-containing factors within spliceosomes (Tronchere et ah, 1997). Other 
proteins related to U2AF^^ have been deseribed. U2AF^^ shows a strong similarity to 
U2AF^^ but lacks an RS domain. Nevertheless, U2AF^^ can associate with U2AF^^ and 
functionally substitute for U2AF^^ in both constitutive and enhancer-dependent splicing 
(Shepard et ah, 2002).
Mammalian SRml 60/300 is a protein complex, consisting of two SR-related nuclear 
matrix proteins of 160 and 300 kDa, that functions as a coactivator of splicing (Eldridge et 
ah, 1999). The SRm l60/300 proteins both contain RS domains but lack recognizable 
RRMs and do not normally bind to pre-mRNA in the absence of other splicing factors. The 
association of SRml60/300 with pre-mRNA requires Ul snRNP, SR family proteins, and is 
stabilized by U2 snRNP. Genetic evidence showed that the interactions between SRml 60
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and SR proteins are important for optimal splicing and proper development in C  elegans 
(Longman et al., 2001). SRml60 was identified as part of the exon-exon junction complex 
(EJC) although it is not a shuttling protein (Blencowe et al., 1998; Le Hir et al., 2000). The 
function of SRml 60 in post-splicing events is not known. In contrast, RNSPl, an SR- 
related protein that act synergistically with SF2/ASF to stimulate both alternative and 
constitutive splicing in vitro (Mayeda et al., 1999a), is also involved in post-splicing events. 
RNSPl was also identified as part of the EJC (Le Hir et al., 2000), and was demonstrated to 
be capable of triggering nonsense-mediated mRNA decay (NMD) when tethered 
downstream of a premature stop codon (Lykke-Andersen et al., 2001). Another SR-related 
protein that was shown to be essential for splicing is the SC35-interacting protein 1, Sip-1 
(Zhang and Wu, 1998). This protein was originally identified by virtue of its interaction 
with SC35 in a yeast two hybrid assay, and subsequent assays indicated that this protein is 
also able to interact with other SR proteins and with U1-70K and U2AF^^.
The U l snRNP-specific protein, U1-70K, harbors an RRM that is essential for 
binding to the Ul snRNA (Etzerodt et al., 1988; Mancebo et al., 1990; Query et al., 1989; 
Spritz et al., 1987; Theissen et al., 1986). It also contains an RS domain, which plays an 
important role in bridging 5' and 3' splice sites by interacting with SR proteins (Cao and 
Garcia-Bianco, 1998; Kohtz et al., 1994; Nelissen et al., 1994). The [U4/U6.U5] tri-snRNP- 
specific 27K protein is a novel SR protein that is required for spliceosome assembly and is 
phosphorylated by a yet unidentified snRNP-associated protein kinase (Fetzer et al., 1997).
CR0P/Luc7A is an SR-related protein that was isolated as an overexpressed gene in a 
cisplatin-resistant cell line (Nishii et al., 2000). CR0P/Luc7A contains leucine zipper-like 
motifs and a carboxy terminal RS domain. Its eounterpart in yeast, Luc7p, was shown to be 
a component of the Ul snRNP and to be involved in 5' splice site selection (Fortes et al., 
1999). Other examples of snRNP-associated proteins containing RS domains are the 65 and
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110 kDa SR-related proteins of the U4/U6-U5 tri-snRNP, which were shown to be essential 
for the assembly of mature spliceosomes (Makarova et a l, 2001), and the U5-100K protein 
(Teigelkamp et ah, 1997). The U5-100K protein is homologous to S. cerevisiae Prp28p, a 
member of the DExD/H-box family of RNA-dependent ATPases that is required for 
eonformational rearrangements in the spliceosome (Staley and Guthrie, 1999). Other SR- 
related proteins required for rearrangements of RNA-RNA and RNA-protein interactions in 
the splieeosome are the DEAH-box family proteins hPrpl6 and HRHl (Ohno and Shimura, 
1996; Ortlepp et al., 1998), and the DEAD-box protein Hell 17 (Sukegawa and Blobel, 
1995).
Some of the kinases that phosphorylate SR proteins contain RS domain themselves. 
Clkl has an RS domain at its N-terminus and interacts with several SR proteins and SR- 
related proteins in a yeast two-hybrid screen (Colwill et al., 1996b; Nestel et al., 1996). 
Clkl was shown to regulate the splicing of C lkl and adenovirus pre-mRNAs in vivo 
(Dunean et al., 1997). Members of the Clk-Sty family of kinases were used to identify new 
SR-related proteins. Using Clk4 lacking kinase aetivity as a bait in a yeast-two hybrid 
screen, another SR-related protein. Clasp, was identified. This protein can be 
phosphorylated by Clk4, and promotes exon EB inclusion of Clkl pre-mRNA in vivo 
(Katsu et al., 2002).
SRrpSO, SRrp40 (SRp38) and SRrp86 are members of the SR-related proteins family 
that act as splicing regulators antagonising SR proteins, and have been already described in 
this chapter (seetion 1.5.). SWAP, Tra and Tra2 were genetieally defined as Drosophila 
alternative splicing regulators (reviewed in Fu, 1995). SWAP contains a C-terminal RS 
domain but lacks RRMs, and autoregulates its expression by suppressing the splicing of its 
own pre-mRNA. Tra is an SR-related protein that lacks an RRM, whereas Tra2 contains a 
single RRM flanked by two RS domains. These proteins are alternative splicing factors that
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function as part of a cascade of alternative splicing events involved in the regulation of sex 
determination in Drosophila (for a review see Schutt and Nothiger, 2000). The protein 
pinin, which contains an RS domain at the C-terminus as well as three coiled-coil domains 
in the first half of the protein, can regulate alternative 5' and 3' splicing (Wang et al., 2002). 
However, the mechanism by which pinin exerts this regulation remains unknown.
SR-related proteins and the transcriptional machinery
RNA processing events are coupled to transcription, and a key factor in this 
coupling is the carboxy terminal domain, or CTD, of RNA pol II (for reviews, see Bentley, 
1999; Bentley, 2002; Maniatis and Reed, 2002; Proudfoot et al., 2002). Yeast two-hybrid 
screens using the CTD of RNA pol II as a bait resulted in the identifieation of a novel 
subgroup of SR-related proteins, collectively referred to as SCAFs (for SR-related CTD- 
associated factors) (Tanner et al., 1997; Yuryev et al., 1996). These proteins contain a short 
RS domain and a subset of them contain a single, divergent RRM. In addition, most of 
them contain a CTD-interaction domain (CID) that is 80-120 amino acids long. The 
mechanism by which this group of proteins link transcription to splicing remains unknown.
Several RNA pol Il-associated factors, not previously recognised as harboring an RS, 
were identified in a genome wide survey of RS domain-containing proteins. These include 
a CTD phosphatase, proteins involved in transcriptional elongation and several factors 
involved in transcription initiation (Boucher et al., 2001). All these proteins are potential 
mediators in the communication between the transcription and splicing machines. It was 
demonstrated that the elongation rate of RNA pol II can influence alternative splicing 
(Kadener et al., 2001; Kadener et al., 2002; Nogues et al., 2002), and these proteins are 
good candidates to mediate this effect. Another surprising consequence of the coupling of
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transcription and splicing is that the promoters that drive the transcription of a gene can 
influence the decisions made by the spliceosome hundreds or thousands of nucleotides 
downstream (Cramer et ah, 1999). The molecular basis of this effect is unknown. One 
possibility is that the promoter somehow determines the elongation rate of RNA pol II. An 
alternative explanation is that factors that are specifically recruited to individual promoters 
can affect splicing directly. The later possibility is supported by the discovery of two SR- 
related proteins that bind promoters like classical transcription factors, PCGl (Monsalve et 
al., 2000), whieh eontains an RS domain and an RRM and can bind SR proteins directly in 
vitro, and the papillomavirus E2 protein (Lai et al., 1999). It is now known whether these 
proteins remain bound to the promoter and influence splicing at a distance or whether they 
are loaded onto the departing RNA pol II and influence splicing locally. Another protein 
that could be important in the communication between these machineries is NREBP/SON. 
NREBP/SON binds a negative regulatory element (NRE) loeated immediately upstream of 
the upstream regulatory sequence of core promoter and second enhancer of human hepatitis 
B virus (HBV), repressing the transcription of HBV genes and the production of HBV 
virions (Sun et al., 2001). NREBP/SON contains an RS domain and three groups on 
evolutionary conserved peptide repeats, and co-localises with the SR protein SC35 and with 
snRNAs in nuclear spleekles (Wynn et al., 2000), although it is unknown if this protein has 
a role in splicing.
SR-related proteins and 3'-end processing
The processing of 3' end of pre-mRNAs is important for subsequential steps in the 
gene expression pathway including definition of terminal exons during splieing, mRNA 
stability, transport, and translation. It has been well documented that pre-mRNA splicing
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and 3' end processing can influence each other. During splicing of the terminal 3' intron, 
splicing factors can interact with polyadenylation factors and promote 3' end cleavage and 
polyadenylation (McCracken et al., 2002; Vagner et al., 2000). Reciprocally, 
polyadenylation complexes are believed to promote splicing of the upstream 3' introns. This 
idea is supported by the observation that mutations of the poly (A) signal at the distal end 
of a 3'-terminal exon, inhibits splicing of proximal but not distal introns in vitro (Niwa and 
Berget, 1991). A good candidate for linking 3'-end formation and splicing is an SR-related 
protein, the 68 kDa subunit of the cleavage factor I (CFI) (Ruegsegger et al., 1998). CFI, 
together with CFII, the cleavage-polyadenylation specific factor (CPSF), the cleavage- 
stimulation factor (CstF) and the poly(A) polymerase, form a multiprotein complex that is 
responsible for executing the two steps of the polyadenylation reaction. Other factors that 
could link splicing and 3'- end formation via RS domain-mediated interactions are two SR- 
related proteins identified in D. melanogaster and C  elegans that are related to Fipl, a 
factor involved in the polyadenylation step of 3'-end formation in S. cerevisiae (Boucher et 
al., 2001).
SR-related proteins and cell structure
Several SR-related proteins are actin-binding proteins or are related to proteins with 
funetions associated with the cytoskeleton. One of them, the nuclear matrix-associated 
protein SRml60/300, is discussed above. Another example is the Band 4.1 family of 
proteins. This family of proteins is believed to promote the anchoring of the cytoskeleton to 
the outer membrane by promoting the interaction of spectrin and actin in erythrocytes. 
Band 4.1 proteins localise to the nuclear speckles (Krauss et al., 1997) and interact with 
members of the SR family of proteins (Lallena et al., 1998). Another example of actin-
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binding proteins that contain RS domains is the S. cerevisiae Slalp protein (Boucher et ah, 
2001). It has been postulated that the function of actin or actin-like proteins in the nucleus 
is to form a nuclear homologue of the actin cytoskeleton that might facilitate the 
organisation of processes in the nucleus (Rando et ah, 2000). Thus, SR-related proteins 
related to actin or actin-binding proteins could serve as anchors of the RNA processing 
machines and the nuclear matrix.
1.11. Identification of new factors invoived in RNA processing
Although several components of the spliceosome and other RNA-processing 
machineries have already been characterised, many factors involved in these processes 
remain unidentified.
Historically, most mammalian RNA processing factors have been identified by 
genetics analysis, biochemical fractionation and purification, using antibodies recognising 
splicing factors, and by sequence homology. Developm ents in protein 
microcharacterisation using mass spectrometry have allowed the identification of many 
components of the spliceosome both in yeast (Gottschalk et al., 1998; Neubauer et al.,
1997) and in mammals (Neubauer et al., 1998). This technology also allowed the 
identification of components of biochemically purified nuclear bodies, such as the 
interchromatin granules (IGC) which are components of the nuclear speckles (Mintz et al., 
1999), and the nucleolus.
The spliceosome is one of the most studied complexes using these methods (Jurica 
and Moore, 2003). As described in section 1.4., spliceosome assembly proceeds through a 
series of sucomplexes or intermediates. The most common approach to date has been to
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work with mixtures of assembly intermediates assembled in vitro (Gottschalk et ah, 1998; 
Rappsilber et ah, 2002; Zhou et ah, 2002). The aim of this approach is to identify every 
factor involved, regardless at what stage of the splicing pathways it works. However, some 
recent reports described the purification and mass spec analysis of three spliceosomal 
subcomplexes (Hartmuth et al., 2002; Jurica et al., 2002; Makarov et al., 2002). This 
approach presents several drawbacks (Jurica and Moore, 2003). One of the problems is to 
determine which proteins are truly spliceosomal and which are contaminants. Some 
proteins can be detected in mass spec experiments simply because they are very abundant 
in the cell and contaminate any preparation. So, some proteins reported as spliceosomal 
factors could merely be contaminants, whereas some real spliceosomal components could 
have been mistaken as contaminants and therefore not included in the reports. Similarly, 
since splicing complexes contain RNA, some proteins reported could have been co-purified 
with spliceosomes simply because they bind RNA. Additionally, it is difficult to distinguish 
which proteins are specific pre-mRNA splicing factors and which are core factors, required 
for the splicing of every intron. Another problem is that if a protein is not detected by this 
approach, it does not necessarily mean that the protein is not a spliceosomal component. 
For instance, some of the U6 core snRNP proteins were undetectable in complexes that 
clearly contained U6 snRNA. Furthermore, many loosely associated factors can be lost 
during purification steps. Despite its well characterised role in the second step of splicing, 
Prpl8 was undetectable in purified C complex by either mass spec or Western blotting 
(Jurica et al., 2002).
The gene trap methodology is an excellent experimental strategy that can be used to 
identify and mutate novel genes in order to uncover their biological function (for a review, 
see Cecconi and Meyer, 2000). Gene traps have been successfully used to isolate genes 
with interesting patterns of expression during development (Evans et al., 1997), or to obtain
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sequence from large numbers of randomly trapped genes (Zambrowicz et al., 1998). This 
gene trap strategy can be modified in order to allow the identification of novel proteins of 
unknown function that localised to different subnuclear compartments, including splicing 
speckles (Tate et al., 1998).
1.12. Conclusions
In the preceding sections, some of the components that play a role in the biochemical 
reaction of splicing were described. Although numerous metazoan splicing factors have 
already been identified and characterised through biochemical and other approaches, it is 
clear that there is still a large number of factors that remain unidentified. The recognition 
and description of all the factors that take part of this process should help to fill the current 
gaps in the picture of splicing. The comprehensive analysis of the complete genomes of 
different organisms has uncovered many new RS domain-containing proteins with 
unknown functions. The functional characterisation of such proteins should lead to a 
dramatic increase in our knowledge of alternative splicing regulation and of the mechanism 
by which the spliceosome accomplishes the splicing reaction.
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Materials and Methods
2.1. Plasmid constructs
All constructs used in this thesis were generated by PCR amplification of the 
fragment of interest and subsequent ligation into the corresponding vector. Useful 
restriction sites were incorporated in the primers used for PCR amplification with Vent 
(NEB) proofreading DNA Polymerase. PCR fragments were then purified using 
QIAQUICK PCR Purification Kit (QIAGEN) and digested with the corresponding 
restriction enzymes, which was carried out using the appropriate buffer and temperature 
recommended by the manufacturer (Roche). Ligation of DNA fragments was carried out in 
10 p,l reactions, containing approximately 100 ng of DNA (vector + insert) with a molar 
relation of 3:1 between insert and vector, and 400U of T4 DNA Ligase (NEB) and reactions 
were incubated o/n at 16°C. Normally, half of the ligation reactions were transformed into 
DH5a Subcloning Efficiency competent cells (Invitrogen), following manufacturer's 
protocol. Identity and orientation of the insert in positive clones were confirmed in every 
case by both digestion with restriction enzymes and sequencing (see section 2.3 for 
sequencing protocol).
2.1.1. C loning and seq u en c in g  of m USSRp58 and hU SSR p58
Mouse and human versions of USSRp58 (hereinafter, mUSSRp58 and hUSSRp58, 
respectively) were cloned by RT-PCR from total RNA of mouse ES cells or human Hep3B 
cells, respectively. Total RNA was prepared using Total RNA Isolation Reagent (ABgene)
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according to manufacturer's specifications. Approximately 5 pg of total RNA were used for 
synthesis of first-strand cDNA with SuperScript^^II RNase H' reverse transcriptase 
(Invitrogen), following manufacturer's protocol, and 10% of the cDNA obtained in each 
case was used for PCR amplification. A fragment corresponding to the full-length coding 
sequence o f mUSSRp58 was am plified using a forw ard prim er 5'- 
TCGACTAGTGGACGCCGGTCTTCAGACACT-3' and a reverse prim er 5'- 
CGAGGATCCTTAGGCCACGGGACTGCCCAT-3'. that introduce Spel and Barnm  
restriction sites, respectively (sequence recognized by the restriction enzymes is 
underlined). For the human sequence, the following primers that also introduce Spel and 
BamYll s i t e s  w e r e  u s e d :  F o r w a r d  p r i m e r  5 ' -
TCGACTAGTGGACGTCGGTCATCAGATACT-3' and reverse prim er 5'- 
CGAGGATCCTTAGGCCACAGGACTGCCCAT-3'. These fragments were then digested 
with Spel and BamYll, ligated to pBlueScript SKIT and fully sequenced. This constructs 
were designated pBS-mUSSRp58 and pBS-hUSSRp58, respectively.
2.1.2. E pitope-tagged ex p ress io n  p lasm id s
The mammalian expression vector pCGT7 used to express mUSSRp58 and h-319RS 
has been previously described (Caceres et al., 1997). Transcription is driven by the CMV 
enhancer/promoter, and the coding sequence begins with an N-terminal epitope tag, 
MASMTGGQQMG, which corresponds to the first eleven residues of the bacteriophage T7 
gene 10 capsid protein and is recognized by the T7-tag monoclonal antibody (Novagen). 
Due to the presence of an internal X bal site in the USSRp58 cDNAs, the amplified 
fragments were designed with Spel and BamH I sites and were subcloned into the Xbal- 
BamR I sites of pCGT7. The following primers were used:
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mUSSRp58
Forward primer 5'-TCGACTAGTGGACGCCGGTCTTCAGACACT-3'
Reverse primer 5'-CGAGGATCCTTAGGACACGGGACTGCCCAT-3' 
hUSSRp58
Forward primer 5'-TCGACTAGTGGACGTCGGTCATCAGATACT-3'
Reverse primer 5'-CGAGGATCCTTAGGACACAGGACTGCCCAT-3'
These plasmid constructs were designated pCGT7-mUSSRp58 and pCGT7-hUSSRp58, 
and were used for transient expression in a variety of cell lines.
A plasmid expressing hLuc7a was prepared in a similar way. A fragment encoding 
full-length hLuc7a was amplified by RT-PCR from total RNA purified from HeLa cells. 
The prim ers used to am plify hLuc7a were a forw ard prim er 5'- 
GCTCTAGAATTTCGGCCGCGCAGTTGTTG-3' and a reverse prim er 5'- 
CGGGATCCATTGGACTGAGTGTCACCTTC-3'. that introduce A6al and Barnm  sites, 
respectively. This fragment was digested with these restriction enzymes and ligated into the 
Xbal-Bamm  sites of pCGT7.
A fusion of mUSSRp58 to GFP was constructed by amplification of mUSSRp58 with 
specific primers and the resulting PCR product was subcloned as EcoBl-Bamm  fragment 
into either pEGFP-Cl (NH2-terminal tag) or pEGFP-N 1 (C- terminal tag)(Clontech). The 
fragm en t for p EG F P - C l  was ampl i f i ed  wi th the p r imer  5'- 
CGGAATTCGCCACGGGACTGCCCAT-3' and the reverse pr imer  5'- 
CGGGATCCTTACGGCACGGGACTGCC-3'. digested with EcoRI and Barnm , and 
ligated. The primers used to amplify the fragment ligated to pEGFP-Nl were 5'- 
CGGAATTCATGGGACGCCGGTCTTCAGAC-3' as forward primer (the translation 
initiation codon is in bold). These two plasmid constructs were designated pEGFPNl- 
USSRp58 and pEGFPC 1 -USSRp58, respectively.
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2.1.3. P lasm ids u sed  for y e a st two-hybrid an a lysis
The bait plasmids used for yeast two-hybrid screening and direct yeast two-hybrid 
analysis were constructed by inserting PCR fragments into plasmid pGBKT7. The bait 
construct used for two-hybrid screening, designated as pGBKT7-mUSSRp58 was 
constructed by amplifying a USSRp58 cDNA with specific primers, and the resulting PCR 
product was subcloned as EcoRI-BamHI fragment into pGBKT7 (Clontech).
Primers:
Forward: 5'-TCGGAATTCGGACGCCGGTCTTCAGACACT-3'
Reverse: 5'-CGAGGATCCTTAGGCCACGGGACTGCCCAT-3'
pGBKT7-319Nterm was constructed by amplification of mUSSRp58 (aminoacids 1-164) 
with specific primers and the resulting PCR product was subcloned as EcoBl-Sall fragment 
into pGBKT7 (Clontech).
Primers:
Forward: 5'-TCGGAATTCGGACGCCGGTCTTCAGACACT-3'
Reverse: 5'-ACGCGTCGACGCCTTTGATGCTGTGCACTT-3'
pGBKT7-319Cterm was constructed by amplification of mUSSRp58 (amino acids 165- 
334) with specific primers and the resulting PCR product was subcloned as EcoBl-Sali 
fragment into pGBKT7 (Clontech).
Primers:
Forward: 5'-CGGAATTCGGGGATTCTGGAAACATCAAA-3'
Reverse: 5 -ACGCGTCGACGGCCACGGGACTGCCCA-3'
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The constructs used for direct yeast two-hybrid analysis expressing SR proteins as 
preys were generated by inserting PCR fragments into plasmid pACT2 (Clontech). The 
following pairs of primers were used to amplify PCR fragments corresponding to the full- 
length coding sequence of different SR proteins:
SF2:  5 ' - T C C C C C G G G G T C G G G A G G T G G T G T G A T T - 3 '  and  5' -
GGAATTCTTAGGTACGAGAACGGCAGCG-3'. that introduce Sm al and EcoM  
restriction sites respectively.
S R p 5 5 :  5 ' - C G GGATCCC G C G C G T C T A C A T A - 3 '  a n d  5 ' -
GGAATTCTTAATCTCTGGAACTCGA-3'. introducing Barnm  and EcoBl restriction 
sites, respectively.
SRp40:  5 ' -TCCC C C GG GGAGTGGCTGTCGGGTATTCATC- 3 '  and 5'-
GG A ATT CTT A ATT GCC ACT GT C A ACT GA-3 '. introducing Smal and EcoBl restriction 
sites, respectively.
SRp20:  5 ' - CATGCCATGGA T C G T G A T T C C T G T C C A T T G - 3 '  and 5'-
GGAATTCCTATTTCCTTTCATTTGACCTA-3'. introducing Ncol and EcoBl restriction 
sites, respectively.
9 G 8 :  5 ' - C A T GCCATGGC G C G T T A C G G G C G G T A C - 3 '  a n d  5 ' -
CGGGATCCTCAGTCCATTCTTTCAGGACT-3'. introducing Ncol and Bam m  
restriction sites, respectively.
In each case, the PCR fragment was purified, digested with the appropriate 
restriction enzymes and ligated to the corresponding sites into the pACT2 vector.
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2.1.4. P lasm ids for ex p ress io n  in B aculovirus sy stem
For overexpression and purification of recombinant m319RS in Baculovirus system, 
full-length mUSSRp58 fused to c-myc and 6xHis as carboxyl terminal tags was amplified 
by PCR and inserted into the plasmid pVL1392 (Pharmingen).
The following pairs of primers were used to amplify a PCR fragment: 5'- 
CGGAATTCATG GGTCGCTCTTCA GACACT-3' and reverse  p rim er 5'- 
CGGGATCCCtATGVGTCGACGGC-3'. These primers introduce EcdBl and B arnm  
restriction sites, respectively.
2.2. Antibodies
2.2.1. Production and purification of an tib od ies aga in st USSRpSS
An adult rabbit was injected with two synthetic peptides conjugated to KLH. Pre- 
immune bleeds were collected, and animals were injected with the mix of peptides 
conjugated to KLH, and boosted four weeks later. Two weeks after the boost the first bleed 
was collected. The animal was injected again two weeks after the first bleed, and the 
second immune bleeds were collected two weeks later. The same procedure of 
immunisation and bleed after two weeks was repeated two more times, until a satisfactory 
immunoresponse was obtained. The two peptides (Resgen) used for injection were the 
following:
- PEPl (H-CEEEAKRRKEEDQATL-OH), corresponding to USSRp58 amino acid 
sequence 207 to 221.
- PEP2 (H-CLIALRQERLMGSPVA-OH), corresponding to USSRp58 amino acid 
sequence 319 to 334.
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These peptides were resuspended in a solution containing 50 mM Tris pH 8.5, 5 mM 
EDTA and 10% glycerol, and two columns (one for each peptide) were prepared by 
coupling 2 mg of peptide to 1 ml of SulphoLink® Coupling Gel (Pierce), following 
manufacturer's protocol.
Approximately 20 ml of serum from the fourth bleed were used to affinity purify 
antibodies. Addition of caprylic acid to serum was used to precipitate most serum proteins 
with the exception of the IgG molecules. . Two volumes of 60mM NaAcO pH 4.0 were 
added, and the pH was adjusted to 4.8. Then, 1.5 ml of caprylic acid were added dropwise, 
and left to stir for 30 min. at RT. Then, the mix was centrifuged 10 min at 5000g and the 
supernatant was recovered and neutralized with 1/10* volume of lOX PBS. The supernatant 
was cooled to 4°C and 0.313g/ml of finely ground ammonium sulphate was added slowly 
while stirring for approximately 2 hours, to bring to a final concentration of 50% of 
saturation. Then the mix was centrifuged at 3000g for 30 min. After centrifugation, the 
supernatant was carefully decanted and the pellet (containing antibodies) was resuspended 
in 10 ml of PBS and dialysed overnight in 3 changes of PBS at 4°C. Next day, the dialysed 
IgG was loaded onto the column containing immobilised PEPl (previously equilibrated 
with PBS), and the eluate was passed through the column two more times. Then, the eluate 
was applied to the second column, containing immobilised PEP2, and the same procedure 
applied on the first column was repeated with the eluates on this column. Columns were 
then washed with 20-bed volumes of lOmM Tris pH 7.5 and then with 20-bed volumes of 
0.5 M NaCl, 10 mM Tris pH 7.5. Antibodies that were bound by acid-sensitive interactions 
were eluted by passing 10 bed-volumes of lOOmM Glycine pH 2.5 through the column, 
passing 850 pi at a time, and collecting the fractions in an eppendorf tube containing 150 pi 
of 1 M Tris pH 8.0. The columns were then washed with 100 mM Tris pH 8.8 until the pH
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of the eluate was 8.8. Then, antibodies that were bound by base-sensitive interactions were 
eluted in ten fractions of 850 pi of freshly prepared 100 mM triethylamine pH 11.5. 
Fractions were collected in eppendorf tubes containing 150 pi of 1 M Tris pH 8.0. Columns 
were then washed with 10 mM Tris pH 7.5 until the eluate reached a pH of 7.5. Columns 
were regenerated by washing with 8 bed-volumes of PBS, then equilibrated with deionized 
water containing 0.05% NaNg and 10 mM EDTA, and stored at 4°C. The protein content of 
the eluted fractions was monitored by reading the absorbance at 280 nm. The basic and acid 
fractions containing protein were pooled and dialysed overnight at 4°C against PBS plus 
0.05% NaNs. The next day, the purified antibodies were adjusted to 10% glycerol, 1 pg/ml 
BSA, 0.02% NaNs and stored at 4°C or frozen at -20°C for later use.
2.2.2. Other antib od ies
Monoclonal antibody against T7-tag was obtained from Novagen. This antibody was 
used in a dilution 1:1000 for immunofluorescence experiments and in a dilution 1:10000 
for Western blots. Monoclonal antibodies against SC35 (Fu and Maniatis, 1990), were 
kindly provided by Dr. Xiang-Dong Fu. These antibodies were used in a dilution 1:500 for 
immunofluorescence. Monoclonal antibodies (mAb96) against SF2/ASF (Hanamura et al., 
1998) were provided by Dr. Adrian Krainer. These antibodies were used for Western blots 
in a dilution 1:500. The Y12 mAh (Lemer and Steitz, 1979) was kindly provided by Dr. 
Wendy Bickmore.
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2.3. Sequencing of DNA
PCR fragments or plasmid DNA were sequenced using BigDye™ terminator cycle 
sequencing ready reaction (Applied Biosystems). A reaction usually contained 
approximately 500ng of DNA, 4 pi of reaction mix, 1 pi of primer 5 pM and dHzO up to 10 
pi. The sequencing program was run on a DNA engine PTC-200 (Peltier Thermal Cycler), 
and the program used consisted of an initial cycle of dénaturation at 96°C for 3 min., 
followed by 25 cycles of dénaturation at 96°C for 30 sec., annealing at 50°C for 15sec., and 
elongation at 60°C for 4min. The samples were then precipitated with EtOH, the pellet 
washed with 70% EtOH, and air-dried. The samples were then loaded on an ABI 377 
machine, and the results analyzed using the ABI Sequencing Analysis 3.0 software.
2.4. Northern blot
To study the expression profile of 319RS in adult mouse tissues, a Multiple Tissue 
Northern (MTN®) was obtained from Clontech. According to the manufacturer, these blots 
are prepared with full-length poly A^ transcripts with virtually no genomic DNA 
contamination. The blots contain approximately 2 pg of purified poly (A)^ RNA per lane. 
The probe used to hybridise the blot was prepared by digesting pBS-mUSSRp58 with the 
restriction enzymes Stul and Xbal, resulting in a fragment of 179 bp that would hybridise 
close to the 5' end of the coding sequence of USSRp58. This fragment was gel purified and 
labelled by random-priming using the HighPrime Kit (Roche), and hybridisation was 
performed following manufacturer’s instructions.
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For the detection of snRNAs, precipitated total RNA was separated in a 10% urea- 
PAGE, and transferred to Hybond N+ membrane (Amersham) using a Genie Blotter unit 
(Idea Scientific Company). The transfer was performed in 89 mM Tris-Borate, 2mM 
EDTA, pH 8.3, at 12 volts for 30 min. The immobilised RNA was then fixed to the 
membrane by incubation at 80°C for 2 hours. Small nuclear RNAs were detected with the 
following specific oligonucleotides:
U1 snRNA: 5'-ACCTTCGTGATCATGGTATCTCCCCTGCCAGGTAAGTATC-3’
U2 snRNA: 5'-GATACTACACTTGATCTTAGCCAAAAGGCCGAGAAGCGAT-3'
U4 snRNA: 5'-GATAAACCTCATTGGCACGATACTGCCACTGCGCAAAGCT-3'
U5 snRNA: 5'-AGGCGAAAGATTTATGCGATCTGAAGAGAAACCAGAGTAT-3'
U6 snRNA: 5'-ATCGTTCCAATTTTAGTATATGTGCTGCCGAAGCGAGCAC-3'
These oligos were labeled with polynucleotide kinase and purified using a Nucleotide 
Removal Kit (QIAGEN), following manufacturer's instructions. The blot was hybridised 
with a mix of the labelled probes in UltraHyb buffer (Ambion) at 42°C. Washes were 
performed as suggested by UltraHyb User's Manual, and the blot was exposed to an X-ray 
film.
2.5. Western blot
Samples were separated by SDS-PAGE and electroblotted onto Hybond-P 
(Amersham) in 25 mM Tris-base, 40 mM glycine and 20% methanol in a Genie Blotter unit 
(Idea Scientific Company), at 12 volts for one hour. The membranes were blocked with 5% 
nonfat dry milk in TBST (20 mM Tris pH 7.5, 137 mM NaCl and 0.1% Tween 20) for one 
hour at RT or overnight at 4°C. Incubations with primary and secondary antibodies were
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carried out for one hour at RT in TBST containing 5% nonfat dry milk. Five washes with 
TBST were done after incubations with each antibody, and immunoreactive protein bands 
were detected with the SuperSignal system (Pierce) according to the manufacturer's 
instructions.
Protein samples from adult mouse tissues were prepared by homogenisation with T25 
Basic Ultra Turrax (IKA Laboratechnik) in boiling lysis buffer (50 mM Tris pH 7.5, 10% 
glycerol, 0.05% SDS, 150 mM NaCl, 2.5% P-mercaptoethanol, 1 mM EDTA). Insoluble 
material was removed by centrifugation, and the protein concentration of each sample was 
determined using Bio-Rad Protein Assay system (Biorad) with BSA as a standard.
For preparation of protein samples from cells grown in culture, cells were washed 
with phosphate buffered saline (PBS) and collected by centrifugation. Cells were then 
resuspended in lysis buffer and boiled for 10 min and the protein content of the samples 
was determined as described above.
2.6. Cell culture and transfections
HeLa, 293T and 3T3 cell lines were grown in Dulbecco's modified Eagle's medium 
(Invitrogen) supplemented with 10% fetal calf serum, and incubated at 37°C in the 
presence of 5% CO2. Hela and 293T cells were transfected with 3 pg of DNA and 5 pi of 
Lipofectamine 2000 (Invitrogen) per well in 6-well plates or with 15 pg of DNA and 45 pi 
of Lipofectamine 2000 per 10cm dish, according to manufacturer's instructions.
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2.7. Indirect immunofluorescence
Cells were fixed and permeabilized for immunofluorescence assays at 24 hrs after 
transfection. Fixation was with 4% p-formaldehyde in PBS for 15-30 min at room 
temperature, followed by incubation for 10 min in 0.2% Triton X-100 in PBS. Fixed cells 
were then incubated for 1 hr at room temperature with the first antibody, washed with PBS, 
and incubated for 1 hr at room temperature with a secondary antibody, followed by further 
washes with PBS. The samples were observed on a Zeiss Axioskop microscope and the 
images were acquired with a Photometries CH250 cooled CCD camera using Digital 
Scientific Smartcapture extensions in software from IP Lab Spectrum.
2.8. Nucleocytoplasmic shuttling assays
For transient transfections involving interspecies heterokaryons, due to the need for 
higher transfection efficiency, transfections were carried out by electroporation using 10 pg 
of plasmid DNA per 60-mm dish of 70-80% confluent cells in the presence of 20 pg of 
carrier DNA. Transfected HeLa cells were seeded on coverslips, followed by co-incubation 
with an excess of untransfected mouse NIH 3T3 cells for 3 hr in the presence of 50 pg/ml 
cycloheximide. The concentration of cycloheximide was then increased to 100 pg/ml, and 
the cells were incubated for an additional 30 min prior to fusion. Cell fusions were done as 
described (Pinol-Roma and Dreyfuss, 1992), and the heterokaryons were further incubated 
for 2 hr in media containing 100 pg/ml cycloheximide prior to fixation.
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Immunofluorescence with the anti-T7 monoclonal antibody was performed as described 
above, except that DAPI was included at 5 pg/ml.
2.9. Yeast two-hybrid
The vectors and strains provided in the Matchmaker Two-Hybrid System 3 
(Clontech) were used to screen a Pre-transformed Mouse Brain Matchmaker cDNA 
Library. The library is pre-transformed in Saccharomyces cerevisiae host strain Y187 
(MATa). The construct expressing the bait is transformed in the Saccharomyces cerevisiae 
reporter strain AH 109 (MATa), which contains three reporters -HIS3, ADE2, and MELl (or 
LacZ)- under the control of distinct GAL4 upstream activating sequences (UASs) and 
TATA boxes.
Manipulations of the yeast cells were carried out according to manufacturer's 
instructions (Clontech). In brief, the Saccharomyces cerevisiae reporter strain AH 109 was 
transformed with the bait vector and subsequently tested for activation of reporter genes. 
Cells carrying the plasmid construct pGBKT7-m319RS were plated on either SD-Trp/-His, 
SD-Trp/-Ade, SD-Trp/X-a-Gal to check for activation of HISS, ADE2 or MELl 
reporters,respectively. As the cells carrying the plasmid pGBKT7-mUSSRp58 showed 
some growth in the absence of histidine, the ability of this strain to grow in the presence on 
different concentrations of 3-aminotriazole (3-AT) was tested to determine the 
concentration of 3-AT at which the screen was performed.
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2.9.1. Screen  o f cDNA libraries
The protocol used for screening the pre-transformed library is based on (Bendixen et 
ah, 1994). A single colony carrying the pGBKT7-mUSSRp58 in AH 109 strain was used to 
set up a 10 ml culture in Synthetic Dropout (SD) medium lacking Tryptophan (Trp), and 
the culture was grown overnight at 30°C with shaking. The next day, approximately 24 hrs 
after inoculation, this overnight grown culture was used to inoculate two 300 ml cultures of 
SD-Trp with 150 pi and 300 pi, respectively. The two 300 ml cultures were grown 
overnight at 30°C with shaking. The following morning, the culture with an O D ô o o  closest 
to 0.7 to 0.9 was chosen to continue with. A frozen aliquot of the library was resuspended 
directly with 1 ml of YPD medium and added to a flask containing 50 ml of YPD, and 
grown for 30 min at 30°C with shaking. The culture containing the library was then mixed 
with the culture of the cells containing the GAL4-BD Bait construct. Cells were then 
collected onto 0.22 pm GS sterile filters (Millipore) in screwtop bottle by syringing through 
the cells in 20 ml aliquots. Mating was then allowed to proceed by placing the filter discs, 
cell side up, on YPD-agar plates, and incubating at 30°C for 5 hrs. Cells were then 
resuspended from filters by placing them in a sterile petri dish and rinsing them up and 
down with 2 x 500pl of SD medium. All the washes were pooled in a tube, and 500 pi 
aliquots were plated in 14 cm plates containing SD -TrpZ-Leu/ agar in the presence of 3 mM 
3-AT, and incubated at 30°C for five days. Cells were also plated on SD -Trp, SD -Leu and 
SD -Trp/-Leu plates to calculate the mating efficiency and the number of library cells 
screened.
After 5 days, colonies growing in SD -Trp/-Leu/ agar in the presence of 3 mM 3-AT 
were picked and streaked out on plates containing SD -Trp/-Leu/-His/-Ade/X-a-Gal agar, 
and grown for another 5-8 days to check for expression of all three reporter genes (ADE2,
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HISS, and MELl). The colonies that were Ade^, His^ and Mell^ where considered positive 
interactors, and plasmid expressing the preys were then purified and sequenced. Phenotypes 
were confirmed by co-transformation of purified plasmids expressing the prey with either 
pGBKTV or pGBKT7-mUSSRp58 into AH109. Interactors were considered true two- 
hybrid positives if they could activate the three ADE2, HISS, and MELl reporters when co­
transformed with pGBKT7-m319RS and were unable to activate them when co­
transformed with pGBKT7.
2.9.2. Direct two-hybrid an a iy sis
To directly test for the ability of two known proteins to interact, the pGBKT7 derived 
plasmids (expressing the protein of interest as fusion with GAL4 DNA-DB) and the pACT2 
derived construct (expressing the protein of interest as a fusion with GAL4 AD) were co­
transformed into AH 109 strain. The resulting strains were tested for their ability to activate 
reporters, as described above.
2.10. Immunoprécipitation
For immunoprécipitation, 293T cells that were either transfected with a construct 
expressing the protein of interest or mock-transfected, were scraped from 10-cm tissue 
culture plates, collected in 1 ml of cold PBS, and centrifuged at 270g for 3 min in 
Eppendorf tubes. Cells were then resuspended in 800p-l of IP buffer (50 mM Tris pH 7.5, 
300 mM KCl, 5 mM EDTA, 0.5% Triton X-100, 1 mM DTT and Ix protease inhibitor 
cocktail), and incubated for 30 min at 4°C with continuous mixing on a rotary mixer. The
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IP extract was centrifuged at 12000g for 20 min at 4°C, after which the pellet was 
discarded. The supernatant (IP extract) was divided into 200pl aliquots and either used 
immediately or frozen at -20°C for later use. To 200pl of IP extract, 1 pi (100 ng) of anti- 
TV tag mAh (Novagen) or 10 pi of either immune or pre-immune serum and 20 pi of 
protein A or G (Amersham) were added. The IP extract was then incubated at 4°C for 2 hrs 
with continuous rotation. Immunoprécipitation reactions were then washed 4 times with the 
IP buffer and once with PBS. In some cases, after the last wash, beads were treated with 50 
pg/ml of RNAse A for 10 min at 4°C. After RNAse A treatment, beads were resuspended 
in 40 pi of loading buffer (50 mM Tris pH 7.5, 10% glycerol, 0.05% SDS, 2.5% P- 
mercaptoethanol) and boiled for 10 min. For Western blot analysis of immunoprecipitated 
proteins, 10 pi of sample were used.
The protocol used for the analysis of co-immunoprecipitated RNAs has been 
described elsewhere (Makarova et al., 2001). Approximately 30 pi of affinity purified anti- 
US SRp5 8 antibody were bound to 20 pi of protein-A agarose, in the presence of 0.5 mg/ml 
of BSA, 50 pg/ml of total yeast tRNA, and 0.01% NP-40. Alternatively, PEP2 was added 
to the blocking solution at a concentration of 62.5 pg/ml. For immunoprécipitation of total 
snRNAs, 5 pi of Y12 mAb were bound to 20 pi of protein A agarose.
2.11. Detection of snRNAs
For analysis of co-immunoprecipitated RNAs, washed beads were phenol-chloroform 
extracted, and RNAs were precipitated with ethanol and 3' end-labeled with [^^PJpCp. 
Precipitated RNAs were incubated overnight at 16°C in a 10 pi reaction in the presence of 
10 pCi of [^^P]pCp (Perkin-Elmer), lOU of T4 RNA Ligase (New England Biolabs) and Ix
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Ligation Buffer, which was provided with the enzyme. The following day, labelled RNAs 
were precipitated, separated on 10% polyacrilamide-7 M urea gels and detected by 
autoradiography. Alternatively, U6 snRNA was detected by Northern blot, as described in 
section 2.4.
2.12. Purification of proteins
2.12.1. Purification of bulk SR proteins from Hela c e lls
Total SR proteins were purified from HeLa cells following a two salt precipitation 
protocol (Zahler et al., 1992). A pellet of approximately 10  ^HeLa cells (4C Biotech) was 
resuspended in 200 ml of Isolation buffer (10 mM Hepes pH 7.6, 65 mM KCl, 15 mM 
NaCl, 10 mM EDTA, 5 mM DTT, 5 mM KF, 5 mM ^-glycerophosphate, 0.2 mM PMSF), 
and sonicated 10 times for 20 sec on ice. The suspension was centrifuged at 8000 rpm for 
20 min at 4°C, transferred to new bottles and re-centrifuged. The supernatant volume was 
then measured and transferred to a new beaker. While stirring, ground ammonium sulphate 
was added to a final concentration of 65% saturation, and left to stir for two hours. The 
solution was then centrifuged at 8000 rpm for 20 min at 4°C. After centrifugation, the 
supernatant was transferred to a new beaker, and ground ammonium sulphate was added to 
a final concentration of 90% saturation and left to stir overnight at 4°C. The following day, 
the solution was centrifuged in SW28 rotor (Sorvail) at 25000 rpm for 1 hr. The pellet was 
then washed with isolation buffer containing 90% saturation of (NH4)2S0 4 , resuspended in 
10 ml of Dialysis buffer (the same composition of Isolation buffer, except with 1 mM 
EDTA and 1 mM DTT) and dialysed overnight against 2 changes of dialysis buffer. The
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following day, the solution was aliquoted in Eppendorf tubes and centrifuged for 30 min at 
13000 rpm at 4°C. The supernatants were transferred to new tubes and centrifuged for 
additional 20 min. The supernatants were then transferred to new tubes, MgCb was added 
to a final concentration of 20 mM, and left on ice for 20 min. Tubes were centrifuged at 
13000 rpm at 4°C, the pellet was washed with dialyisis buffer containing 20 mM MgCE, 
and re-spinned for 15 min. Finally, the pellet was resuspended in 250 pi of BClOO (20 mM 
Tris pH 7.5, 100 mM KCl, 0.2 mM EDTA and 20% glycerol). The yield and purity of the 
preparation was determined by analysing 1 pi of the preparation on SDS-PAGE.
2.12.2. Purification of recom binant USSRpSS
His-Myc-USSRp58 was purified from Sf9 baculovirus infected cells. The virus 
expressing His-Myc-319RS was generated using a BaculoGold Starter Package kit 
(Pharmingen), following protocols included in the User Manual provided with the kit. 
Three T-150 flasks containing Sf9 cells at approximately 80% of confluence were infected 
with 500 pi of a high titer stock of baculovirus expressing His-Myc-USSRp58. Four days 
after infection, cells were dislodged from the flasks, transferred to 50 ml conical tubes, and 
centrifuged at 450g for 5 min at RT. The supernatant containing the virus was discarded, 
and each pellet was resuspended in 10 ml of binding buffer (50 mM NaP buffer pH 8, 1.5 
M NaCl, 5 mM Imidazole, 0.5% NP-40, 4 mM P-mercaptoethanol, and Ix of EDTA-free 
protease inhibitor cocktail). The suspensions of cells were then pooled and sonicated four 
times for 30 sec. on ice, followed by centrifugation at 17,000g for 20 min at 4°C. During 
the spin, 1 ml of slurry (=0.5 ml of resin) of Ni^^-NTA (Qiagen) was equilibrated by 
washing three times with 10 ml of binding buffer at RT. The cleared lysate was then 
incubated with the Ni^^-NTA beads for 1 hr at 4°C with gentle rocking, followed by a
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centrifugation of 3 min at 450g at RT. The lysate was then removed, and beads were 
washed twice with 25 ml of washing buffer (50 mM NaP buffer pH 8, 1.5 M NaCl, and 20 
mM Imidazole). Following washes, the beads were transferred to Eppendorf tubes, and the 
purified protein was eluted by applying 250 pi of elution buffer (50 mM NaP buffer pH 8, 
1.5 M NaCl, 300 mM Imidazole), rocking 10 min at RT, centrifuging at 3,000 rpm for 1 
min, and placing the eluate in a new tube. The elution step was repeated four more times. 
The eluted fractions were analysed for yield and purity on SDS-PAGE and the fractions 
containing protein were pooled. Imidazole and salts were dialysed away in a step-wise 
manner, by dialysing against BC800 first, followed by BC400 and BClOO (BC800 and 
BC400 have the same composition as in BClOO, except they contain 800 mM and 400 mM 
KCl, respectively). Protein was then fractionated in 20 pi aliquots and stored at -80°C.
2.13. In wVo splicing assays
Transfection of Hela cells was done as described in section 2.6. Briefly, 1 pg of 
expression plasmid was co-transfected with 2 pg of the adenovirus El A reporter plasmid 
pMTElA (Zerler et al., 1986). Approximately 24hs after transfection, RNA was extracted 
using the Total RNA Isolation reagent (ABgene) following manufacturer's instructions. 
Total RNA was analyzed by RT-PCR with Superscript II reverse transcriptase (Invitrogen) 
and AmpliTaq DNA polymerase (Roche), as previously described (van Der Houven Van 
Oordt et al., 2000). ElA  mRNA detection was carried out with the 5' end-labelled exon 1 
forward primer 5'-GTTTTCTCCTCCGAGCCGCTCCGA-3' and the exon 2 reverse primer 
5 '-CT C AGGCT C AGGTT C AG AC AC AGG-3 '. Amplified products were separated by urea- 
PAGE, detected by autoradiography and quantified by Phospholmage analysis.
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2.14. In wïro splicing assays
2.14.1. Preparation of transcripts
Labelled transcripts were prepared in the presence of a CAP analog 
(m7G(5')ppp(5')G) (New England Biolabs) and [a-^^P]GTP (PerkinElmer), as previously 
described (Sanford and Bruzik, 1999). Human p-globin substrate (Krainer et al., 1984) was 
linearised with Bglll and transcribed with T7 RNA polymerase (Ambion). Fushi tarazu 
substrate (Rio, 1988) was linearized with ATzoI and transcribed with T7 RNA polymerase. 
Transcripts were gel purified.
2.14.2. Im m unodepletion of Hela nuclear extracts
In order to immunodeplete nuclear extracts of USSRp58, either anti-USSRp58 
immune serum or pre-immune sera were crosslinked to protein G sepharose beads 
(Amersham). 200 pi of beads were washed twice with PBS and then mixed with 200 pi of 
either anti-319RS serum or pre-immune serum in 4 ml of PBS, and incubated for 1.5 hours 
at RT with gentle rocking. Beads were then washed twice with 5 ml of 0.2 M sodium 
borate. A sample of 5 pi of beads were removed for later analysis, and the rest was 
resuspended in 5 ml sodium borate. Dimethylpimelimidate (DMP) was added to a final 
concentration of 20 mM, and incubated at RT for 30 min. After incubation, 5 pi of beads 
were removed for later analysis. The reaction was then stopped by washing the beads with 
0.2 M ethanolamine pH. 8, and then incubated in the same solution for 2 hours at RT. 
Beads were then washed once with PBS and incubated with 0.1 M glycine pH 3 at RT for 
10 min. to remove all the uncrosslinked antibodies. The beads were then extensively
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washed with PBS and stored in PBS + 0.01% NaNs. The proportion of crosslinked antibody 
was monitored by analysing the samples isolated before and after the addition of DMP by 
SDS-PAGE and Coomassie staining.
The antibodies coupled to beads were washed five times with 1 ml of buffer D/IM 
KCl (20 mM Hepes pH 8, 20% glycerol, 0.2 mM EDTA, IM KCl). HeLa nuclear extracts 
(4C Biotech, Belgium) were brought to 1 M KCl by directly dissolving the appropriate 
amount of crystals. The beads were then incubated for 2 hrs at 4 °C with 200 pi of nuclear 
extracts in Mobicolumns (MOBITEC), on a rotating wheel. The nuclear extracts were then 
removed by centrifugation, and kept on ice, while the beads were incubated at RT for 10 
min with 100 mM glycine pH 3 with rocking. After 10 min, beads were washed 3 times 
with PBS and 3 times with buffer D (IM  KCl), and two more rounds of depletion were 
applied to the nuclear extract. After three rounds of depletion were completed, the depleted 
nuclear extract was centrifuged at 14,000 rpm at 4°C for 5 min, and then was dialysed 
against two changes of buffer D+ (20 mM Hepes pH 8, 20% glycerol, 0.2 mM EDTA, 0.1 
M KCl, ImM DTT, 0.015% NP-40). After dyalisis, the depleted nuclear extract was 
fractionated and stored at -80°C for later use. The protein concentration of the depleted 
extract was determined using Coomassie reagent (Biorad) with BSA as a standard. The 
extent of depletion was calculated by comparison of the depleted extracts with untreated 
extract in SDS-PAGE.
2.14.3. In Wfro sp lic in g
Splicing was carried out in 25 pi reactions containing 3.2 mM MgCb, 1 mM ATP, 20 
mM creatine phosphate, 3% polyvinil alcohol, 30% nuclear extracts or 45% 
immunodepleted/mock-depleted nuclear extracts, complemented with buffer D with 0.1 M
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KCl. Reactions were incubated at 30°C for 1 hr, and then RNAs were purified by 
proteinase K treatment, phenol-chloroform extraction and precipitation. Spliced products 
were analysed directly by electrophoresis on 5% denaturing polyacrilamide gels in Tris- 
Borate-EDTA (TBE) buffer. Gels were dried a d exposed to Phosphorlmager screens.
2.14.3. SI 00 com plem entation  a s s a y s
Assays were performed in 25 pi reactions containing 5 mM MgC^, 5 mM ATP, 6.25 
mM creatine phosphate, 3.65% PEG, 4.8% RNAse inhibitors, and 50% S I00 extracts (4C 
Biotech, Belgium), and were complemented with BClOO or His-My c-U S SRp5 8. Reactions 
were incubated at 30°C for 90 min. Spliced RNAs were purified and analysed as described 
above.
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Results
1.1 .Characterisation of a novei RS domain-containing protein
1.1.1. Identification and clon in g o f USSRp58
A gene trap screen in mammalian cells, in which the selection criterion is the 
subcellular localisation of the gene product, is being used in our laboratory to identify novel 
nuclear proteins. The gene trap system consist of a P-galactosidase-neomycin 
phosphotransferase (Pgeo) reporter gene, lacking its own promoter and AT G that when 
integrated into an intron of an expressed gene is spliced in frame into the gene transcript 
(Fig. 8A) (Tate et al., 1998). Drug selection identifies cells that have integrated the vector, 
in the correct orientation, into an intron of an expressed gene. This transcript encodes a 
fusion protein possessing both neomycin phosphotransferase and P-galactosidase activities 
(LacZ/p-Gal), the latter of which can be detected by a simple histochemical stain (Fig. 8A). 
The value of this screen in mouse cells is that the initial cytological analysis with the light 
microscope gives immediate and detailed information about subnuclear localisation of the 
trapped gene. Integration of the gene trap P-geo construct into the mouse genome ensures 
that the tagged protein is expressed at endogenous levels and in the correct temporal 
fashion. A more detailed analysis of the subcellular localisation of the trapped fusion 
proteins is determined using antibodies against P-galactosidase. The sequence of the 
trapped gene is identified by 5’ rapid amplification of cDNA ends (5’ RACE) from the 
fusion transcript (Sutherland et al., 2001). The use of this approach allows
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Figure 8: Identification of a novel RS domain-containing protein. (A) Strategy for 
gene trap screen. pGTl-3 contain a geo cassette and neo^ enzymatic activities. This is 
preceded by a splice acceptor (SA) derived from the mouse en2 gene and followed by 
a polyadenylation signal (pA). Productive integrations are those which occur in an intron 
of an expressed gene (fusion gene) downstream of coding exons (stippled boxes) such 
that the reporter is spliced in-frame into the gene transcript (fusion transcript). The sub­
cellular distribution of the fusion protein is assessed by X-Gal staining. Sub-nuclear 
localisation of the fusion protein is determined by indirect immunofluorescence with 
anti-gal antibodies. (B) Amino acid sequence of mouse wild-type USSRp58 protein and 
the trapped protein (below), depicting the domains present. The RS domain is in white 
with a black background, whereas the small region rich in glutamic acid and lysine 
(EK-rich region) is in white with a gray background.
us to identify known proteins whose subnuclear localization was not previously recognized, 
and also to identify novel proteins located in a specific subnuclear compartment. One of the 
cell lines, number 319, generated in a screen performed in our laboratory by Kathryn 
Newton, expressed a fusion protein that localised to the nuclear speckles. I decided to study 
this gene, since localisation to the nuclear speckles is diagnostic of involvement in RNA 
processing. Using the sequence obtained by 5’ RACE, an EST contig was generated that 
identified an open reading frame (ORE) predicting a putative protein. This sequence was 
used to design PGR primers that were used to amplify full-length cDNAs by RT-PCR from 
total RNAs of mouse ES cells and human Hep3B cells. These cDNAs were fully 
sequenced, and found to match the RIKEN cDNA clone 1200013F24 (sequence accession 
number gi: 27229009). The protein encoded by the gene was called USSRp58 for reasons 
described later in this chapter.
The protein contains 334 amino acids and includes an amino terminal domain rich in 
RS dipeptides and serine-rich regions, followed by a short glutamic acid-lysine (EK) rich 
region, similar to the one found in other splicing factors, such as the SR-related protein, 
SRrp86. The P-geo cassette was inserted in intron 4 of the USSRp58 gene resulting in a 
fusion protein that contains the N-terminal 164 aminoacids and conserves most of the RS 
dipeptides but misses the last 170 amino acids (Fig. 8B). This protein also possesses a 
bipartite nuclear targeting sequence between amino acids 214-230 that coincides with a 
helical region predicted to form coiled coil (180-237), a domain that often mediates protein- 
protein interactions. No homology to any other known protein motifs was found in the 
carboxy terminal half of the protein.
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3.1.2. USSRpSS o rth o logs and paralogs in other s p e c ie s
The entire mouse and human genomes (MGSC3 and NCBI31 versions, respectively) 
were searched with the Rikl200013F4 sequence in order to find orthologous genes in 
humans and possible paralog genes in human and mouse. The human orthologous gene 
(Ensembl gene ENSGOOOOO174891) mapped to human chromosome 3q25.32 (position 
-159Mb in the NCBI31 assembly). There are no similar genes elsewhere in the genome, 
except for a highly similar sequence on chromosome 9q22.1 (position -82.6Mb). This gene 
is described as an Ensembl gene (ENSGOOOOOl77872) and the predicted protein is 75% 
identical. However, a closer look showed that this gene has no introns, no start codon, and 
contains at least one in frame stop codon, all signs of a pseudogene. The same 
characteristics are present in the latest assembly (NCBI33). In mouse, there is also a second 
sequence hit in the genome, on chromosome 10 (position -90.76 Mb). Again, the 5’ and 3’ 
end of the gene are missing (no start codon) and there are no introns, which again indicates 
that is most likely a pseudogene. In rat, there are 3 genes that are homologues to 
Rikl200013F4: Ensembl genes ENSRNOG00000012639, ENSRNOGOOOOOO18049, 
ENSRNOG00000004144. A bovine gene was also found in the TIGR database 
(TC132052).
In addition to these mammals, complete or partial gene sequences were detected in 
chicken, Xenopus (2 genes) and although zebrafish or Fugu orthologs were not found, a 
ortholog was found in medaka fish (Orizia latipes gene) and in trout {Onchorynchus 
mykiss). Also, one potential ortholog was found in the invertebrate chordate Ciona  
intestinalis. Several sequences showing certain homology to this gene were also found in 
Drosophila melanogaster and in C. elegans. An alignment of all the complete Rik proteins 
can be seen in Figure 9.
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Figure 9: Sequence alignment of the human USSRpSS protein with its homologues 
in other species. The human USSRp58 protein is shown aligned by the ClustalW 
method with the corresponding proteins from Mus musculus (mm), Rattus norvergicus 
(rat), Gallus gallus (chicken, Xenopus laevis (xl), and Oryzias latipes (medaka fish, 
ol). Residues identical to those in USSRp58 sequence are shown on a black background, 
residues conserved in 80% of the analysed sequences are shown in dark gray background, 
and residues conserved in 60% of the analysed sequences are shown in light gray 
background. Gaps are shown by dashed lines.
3.1.3. Production of recombinant USSRpSS and anti-USSRpSS antibodies
Despite several attempts I was unable to express this protein in E. Coli and only 
achieved very inefficient expression in the yeast Pichia pastoris (data not shown). 
Nevertheless, this protein could be expressed to satisfactory levels in baculovirus-infected 
Sf9 insect cells, and was purified from these cells as a histidine tagged protein over Ni- 
NTA agarose (Fig. 10). In addition to this histidine tag, a myc-tag was also introduced in 
the recombinant protein for use in future experiments.
Polyclonal antibodies were raised in rabbit against two synthetic peptides that are 
conserved between the human and mouse protein, encompassing amino acids 207 to 221 
(207e e e a k RRKEEDQATL^^^) and the last 15 amino acids o f the protein 
(^^^LIALRQERLMGSPVA^^"^), which were designated PEPl and PEP2, respectively. 
When the sequence of these peptides was blasted against either human or mouse translated 
genomes, the only matches obtained were for the genes that code for USSRp58, suggesting 
that they are likely to be unique to this gene. Serum from the immunised rabbit was affinity 
purified against each of the peptides coupled to a SulphoLink column (Pierce). After 
binding to the different columns, antibodies were recovered only from the column prepared 
with PEP2, suggesting that the animal used did not generate antibodies against PEPl.
The specificity of the anti-USSRp5 8 sera was assayed by Western blot analysis of 
extracts prepared from human 293T cells transfected with a construct expressing a T7 
epitope-tagged version of wild-type human and mouse USSRp58 . Western blot analysis of 
total cell extracts from transfected cells showed that a monoclonal antibody recognising the 
T7 epitope-tag revealed a single band of approximately 58 kDa for both the human and the 
mouse protein, which are identical at the amino acidic level (Fig. 11 A). The deduced 
amino acid sequence predicts a protein of 334 amino acids with a calculated molecular 
mass of approximately 38.66 kDa and a isoelectric point of 11.9.
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Figure 10: Purification of recombinant USSRp58 protein. His-Myc-tagged USSRp58 
(His-Myc-USSRp58) was purified from baculovirus-infected Sf9 cells over Ni-NTA 
agarose. Samples were taken from the input (I), flow-trough (FT), washes (W1 and W2) 
and elutions (El, E2, E3, E4 and E5), and the level of purification was determined by 
SDS-PAGE and Coomassie staining. Protein size markers (kDa) are indicated on the 
left.
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Figure 11: Characterisation of anti-USSRp58 antibodies. (A) 293T cells were 
transfected with plasmids expressing either T7-hUSSRp58, T7-mUSSRp58 or T7- 
SF2/ASF as a control. At 24 hrs post-transfection, whole cell extracts were prepared 
and analysed by Western blot using an anti-T7 monoclonal antibody (Novagen). Protein 
size markers (kDa) are indicated on the left. (B) Anti-US SRp58B4 (bleed 4) antibodies 
(left panel) or pre-immune serum (right panel) were used to probe blots containing 
baculovirus expressed His-Myc-USSRp5 8, and immunoprecipitates prepared with anti- 
T7 monoclonal antibody from extracts of 293T cells transfected either with T7- 
mUSSRp58 or mock transfected. Protein size markers (kDa) are indicated on the right.
Basic proteins have a high mass to charge ratio, resulting in a slower migration in SDS- 
PAGE. Presumably, potential phosphorylation of the serine residues in the RS domain of 
the protein also accounts for its anomalous migration at 58 kDa on SDS-PAGE. Similar 
disparities between predicted molecular mass and observed migration on SDS-PAGE have 
been reported for other RS domain-containing proteins, including SRrp86, U1-70K, and 
SRp75 (Barnard and Patton, 2000; Chaudhary et al., 1991; Zahler et al., 1993).
The serum raised against the synthetic peptides (see above) was able to recognise the 
T7 epitope-tagged USSRp58 protein in total cell extracts of 293T transfected cells that 
were immuprecipitated with the anti-T7 tag antibody. In contrast, no band was detected 
when used to probe an immunoprecipitate from mock-transfected cells (Fig. IIB ). 
Furthermore, the serum was able to cross-react with the baculovirus expressed recombinant 
protein. When the same blot was probed with the pre-immune serum, no bands were 
revealed. Identical results were obtained with the affinity purified antibodies against PEP2 
(data not shown). These results indicate that the antibodies raised against the synthetic 
peptides can specifically recognise the USSRp58 protein.
3.1.4. Subcellu lar localisation  of USSRpSS
The subcellular distribution of endogenous USSRp5 8 protein was analyzed by 
indirect immunofluorescence in HeLa cells. The affinity purified antibodies stained the 
nuclei of HeLa cells exclusively and showed a stronger signal in speckles (Fig. 12A). The 
signal observed with the affinity purified antibody was completely abolished when the 
antibodies where pre-absorbed with PEP2 (data not shown).
HeLa cells transfected with a construct expressing a GFP-tagged version of 
USSRp58, showed that the transiently expressed protein also localised exclusively in the
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Figure 12: Subcellular localisation of USSRpSS. (A) HeLa cells were fixed and the 
subcellular localization of endogenous hUSSRp58 was determined by indirect 
immunofluorescence with an anti-USSRp58 polyclonal antibody that was affinity- 
purified against PEP2 (anti-USSRp5 8AP2), followed by incubation with anti-rabbit 
IgG antibody conjugated with FITC. (B) HeLa cells were transfected with a plasmid 
encoding GFP-mUSSRp58, and fixed at 24 hrs post-transfection. Endogenous SC35 
was detected by indirect immunofluorescence with an anti-SC35 monoclonal antibody 
and TxRD-conjugated secondary antibody (Fu and Maniatis, 1990). Images were 
superimposed to reveal sites of overlap in yellow (merge panel). (C) Effect of transcription 
inhibition on subcellular localization of USSRp58 protein. Hela cells were transfected 
with a plasmid encoding T7-US SRp5 8-cells were incubated with actinomycin D (+ActD) 
plus cycloheximide for 3 hrs and fixed at 24 hrs post-transfection. The localisation of 
the expressed proteins was determined by indirect immunofluorescence with anti-T7 
monoclonal antibody and FITC-conjugated secondary antibody.
nucleus, with a typical speckled pattern (Fig. 12B). Furthermore, GFP-USSRp58 
colocalises with an SR protein, SC35, in a typical speckled pattern (Fig. 12B). Identical 
results were obtained when HeLa cells were transfected with a construct expressing a T7 
epitope-tagged version of wild-type USSRp58 (data not shown).
Speckles are dynamic structures, from which splicing factors are thought to be 
recruited to sites of active transcription (Misteli et al., 1997). Arrest of transcription by 
RNA polymerase II inhibitors such as actinomycin D, cause speckles to become enlarged 
and rounded up (Spector et al., 1993). Indeed, this was observed upon addition of 5pg/ml 
Actinomycin D for 3h to HeLa cells transfected with a T7-tagged version of wild type 
USSRp58 USSRp58 (Fig. 12C). Taken together, these results suggest that USSRp58 may 
be involved in RNA processing and most likely in pre-mRNA splicing.
3.1.5. USSRpSS shuttles between the nucleus and the cytoplasm
It has been shown that many nuclear proteins involved in splicing, as for example 
several hnRNPs (Bennett et al., 1992; Pinol-Roma and Dreyfuss, 1991) and a subset of SR 
proteins (Caceres et al., 1998), shuttle between the nucleus and the cytoplasm. This fact 
suggests that in addition to their nuclear roles in splicing, shuttling proteins may have 
additional post-splicing functions. Many hnRNPs were shown to regulate at least three 
distinct cytoplasmic events: mRNA localisation, mRNA turnover and translation (Gama- 
Carvalho and Carmo-Fonseca, 2001; Shyu and Wilkinson, 2000). Members of the SR 
protein family were also shown to have roles in post-splicing RNA processing as well. Two 
shuttling SR proteins, SRp20 and 9G8,promote mRNA export (Huang and Steitz, 2001), 
most likely acting as adapter proteins for TAP-dependent mRNA export (Huang et al., 
2003).
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Many shuttling proteins accumulate in the cytoplasm when cells are incubated with 
inhibitors of RNA pol II transcription, such as actinomycin D. This effect relies on the fact 
that nuclear re-import of the shuttling protein requires ongoing transcription, and this 
property has been used to identify shuttling proteins (Dreyfuss et ah, 1993). The 
localisation of several nucleo-ctyoplasmic splicing factors, such as SF2/ASF, SRp20 and 
hnRNP A l, changes from the nucleus to the cytoplasm after treatment with actinomycin D, 
whereas others, such as 9G8, remain nuclear, despite the fact that are indeed shuttling 
proteins (Caceres et al., 1998). Incubation of transiently transfected HeLa cells with 
actinomycin D and cycloheximide revealed that USSRp58 remained nuclear under these 
conditions. This experiment alone does not rule out the possibility that USSRp58 shuttles 
from the nucleus to the cytoplasm, but that its re-import is independent of transcription.
To determine whether USSRp58 has the ability to shuttle between the nucleus and the 
cytoplasm, I used interspecies heterokaryons assays (Caceres et al., 1998; Michael et al., 
1995) (Fig. 13A). HeLa cells were transfected with epitope-tagged USSRp58 and were then 
fused to mouse NIH 3T3 cells to form heterokaryons. Prior to fusion, the cells were treated 
with cycloheximide, so that no further protein synthesis takes place in the heterokaryons. 
At 2hr post-fusion, the cells were fixed and stained to examine the distribution of the 
tagged proteins by immunofluorescence microscopy with a monoclonal antibody directed 
against the epitope tag. To distinguish the human and mouse nuclei, the cells were stained 
with the dye DAPI, which gives a characteristic staining of heterochromatin in the mouse 
nuclei. Detection of the tagged protein -  originally expressed in the human cells -  within 
the mouse nuclei in the heterokaryons is indicative of shuttling (and therefore of nuclear 
export). Analysis of heterokaryons formed between human cells expressing T7-tagged 
USSRp58 and mouse acceptor cells, clearly showed that epitope-tagged USSRp58 was 
detectable in both nuclei (Fig. 13B). These data indicate that USSRp58 shuttles
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Figure 13: Analysis of nucleocytoplasmic shuttling of USSRp58 by transient 
transfection in interspecies heterokaryons. (A) Diagram of the experimental approach. 
The dark nuclei indicate localisation of the transiently expressed human SR protein. 
Cycloheximide (CHX) was added prior to fusion to prevent further protein synthesis 
from the human mRNA in the heterokaryons. (B) Detection of the transiently expressed 
USSRp58 protein in interspecies heterokaryons. HeLa cells were transfected with 
pCGT7-mUSSRp58. At 24 hr post-transfection, the cells were treated with cycloheximide 
and subsequently fused with mouse NIH 3T3 cells in the presence of polyethylene 
glycol, to form heterokaryons. The cells were further incubated for 2 hr in the presence 
of cycloheximide, followed by fixation. The localization of the expressed proteins was 
determined by indirect immunofluorescence with anti-T7 monoclonal antibody and 
FITC-conjugated secondary antibody (left panel). The cells were simultaneously 
incubated with DAPI for differential staining of human and mouse nuclei within 
heterokaryons (center panel). The arrows indicate the mouse nuclei within human- 
mouse heterokaryons. Phase-contrast images of the same heterokaryons are shown 
(right panel).
between the nucleus and the cytoplasm, suggesting that this protein could have a role in 
post-splicing mRNA processing.
3.1.6. A n alysis  of th e ex p ress io n  of USSRpSS
The expression of many splicing factors is regulated in a tissue or developmental 
specific manner. For example, the level of expression of SF2/ASF and that of its antagonist, 
hnRNP A l, vary naturally over a wide range in tissues and in immortal and transformed 
cells lines, supporting the notion that changes in the ratio of regulators of splicing can affect 
alternative splicing of different pre-mRNAs in vivo (Hanamura et al., 1998). Northern blot 
experiments were performed to determine the expression of USSRp58 at the RNA level, 
using a partial fragment of USSRp58 cDNA as a probe. This experiment showed that 
USSRp58 is widely yet differentially expressed across a variety of adult mouse tissues (Fig. 
14). Interestingly, three different mRNA isoforms were detected. The major isoform 
migrates at about 3.2 kbp and is strongly expressed in testis, liver and brain, and weakly 
expressed in heart, spleen lung, kidney and skeletal muscle. This isoform most likely 
corresponds to cDNA RIKEN NM 025822 (Accession number gi:27229009), which 
encodes full-length USSRp58. The two other isoforms are strongly expressed in testis, and 
are also detected in liver and heart; however, no expression could be detected in skeletal 
muscle. One of these two isoforms could correspond to cDNA RIKEN AK005242 
(Accession number gi: 12837659), since it should be detected by the probe used. This 
cDNA is predicted to express a shorter isoform of USSRp58 of 222 amino acids, 
comprising the RS domain and the short EK-rich domain. The identity of the third band 
detected is unknown. The integrity of the RNA from each tissue was verified by reprobing
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Figure 14: Northern blot analysis of mouse USSRpSS. A Multiple Tissue Northern 
blot (Clontech) was probed with a ^^P-labelled probe prepared from mUSSRp58 cDNA 
and exposed to autoradiography (upper panel). The size of RNA markers is indicated 
on the left, beta-actin cDNA was used as an internal control (lower panel). Note that 
the human beta-actin cDNA probe strongly cross hybridises to muscle-type actin 
(marked with an asterisk) in heart and skeletal muscle.
the same filter with a human P-actin probe, that strongly cross-hybridises with mouse P- 
actin mRNA.
The predicted molecular mass of USSRp58 is 38 kDa, but Western blot analysis with 
anti-US SRp5 8 peptide antibodies (described above) detected a band of approximately 58 
kDa in total cell extracts from human and mouse cells, suggesting that USSRp58 may be 
postranslationally modified (Fig. 15A). When extracts prepared from different adult mouse 
tissues were analysed in the same way, two major isoforms were observed in all the tissues 
analysed (Fig. 15B). The lower band revealed by the antibody corresponds to USSRp58, 
according the apparent size of the band. A second uncharacterised band of approximately 
66 kDa cross-reacts with anti-USSRp58 antibody. This second band could be also observed 
in HeLa nuclear extracts (see Figure 21 A). To test if  this band corresponds to an 
hyperphosphorylated version of USSRp58, HeLa nuclear extracts were treated with calf 
intestinal phosphatase (CIP) and analysed by Western blot. Surprisingly, after treatment 
with CIP, both bands are not further detected by anti-USSRp58 antibody (data not shown). 
The reasons for this result are not known at the moment. Possibly, anti-USSRp5 8 antibody 
could be recognising a phosphoepitope present in USSRp58. Other explanation could be 
that after treatment with CIP, the overall charge of USSRp58 changes considerably, 
changing the migration properties of USSRp58 in the transfer buffer. This hypothesis will 
be tested in the near future. The 66 kDa cross-reacting band could also correspond to an 
alternatively spliced isoform of USSRp58, or alternatively represent a post-translational 
modification other than phosphorylation. As mentioned in section 3.1.3., the sequences of 
the peptides used to raise the antibodies were used in a BLAST search against the human 
and mouse translated genomes. The only match obtained in each case was the gene that 
expresses USSRp58, suggesting that is unlikely that anti-USSRp58 antibody would 
recognise a completely unrelated protein, although this possibility cannot
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Figure 15: Expression of USSRp58 in tissues and cultured cells. (A) 10 ug of total 
protein from different cell lines were separated by SDS-PAGE and transferred to a 
nitrocellulose membrane. The membrane was then probed with anti-US SRp58B4 
(Bleed 4) antibody. Protein size markers (kDa) are indicated on the left. (B) 50 ug of 
total protein from each of the mouse tissues indicated above were analysed as described 
in (A). The band corresponding to the uncharacterised protein recognised by anti- 
USSRp58B4 antibody is marked with an asterisk. Protein size markers (kDa) are 
indicated on the left.
be discarded at present. This band is currently being characterised by different means. The 
results obtained from Northern and Western blot analyses showed that USSRp58 is 
ubiquitously expressed but shows a tissue-specific or cell type-specific level of expression, 
as it has been reported for many other splicing factors (Cowper et al., 2001; Hanamura et 
al., 1998; Screaton et al., 1995; Shepard et al., 2002). This is consistent with a potential role 
for USSRp58 as a splicing regulator.
3.1.7. USSRpSS interacts with sp lic ing  factors in two-hybrid a n a ly sis
In order to identify interacting proteins, yeast two-hybrid screens were carried out 
with the full length sequence of USSRp58 as a bait (Chien et al., 1991). The cDNA 
encoding the full-length mouse USSRp58 protein was cloned into the pGBKT7 vector 
(Clontech), resulting in the pGBKT7-USSRp58 vector. This construct, that would express 
full-length USSRp58 as a fusion protein with the DNA binding domain of GAL4 
transcription factor, was transformed in the Saccharomyces cerevisiae strain AH 109, and 
used to screen a mouse brain cDNA library pretransformed into the S. cerevisiae strain 
Y187 (MATCHMAKER System 3, Clontech). At least 1.5 x 10  ^ individual library 
plasmids were screened. The system provides three interaction reporters that can be tested. 
Positive clones that could activate the three reporters were grown, plasmids were isolated, 
and the interaction was confirmed by re-transformation of the purified plasmids. Once the 
interaction was confirmed, library plasmids were sequenced and the identity of the 
interacting protein was determined.
In support for a role of USSRp58 in pre-mRNA splicing, I identified Luc7p and 
HCCl, two splicing regulators, as interacting proteins. Most of the clones obtained are 
derived from these two genes and other two RS domain-containing proteins (Fig. 16A).
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Figure 16: USSRp58 interacts with RS domain-containing proteins in a yeast two- 
hybrid system. (A) Reconstitution of two-hybrid interactions found in a yeast two-hybrid 
screen. The upper panel shows growth on selective media without Adenine, and the lower 
panel shows activation of the MELl reporter. In each panel, yeast cells were co-transformed 
with each of the prey plasmids (pGAD) isolated from the screen (indicated above) and bait 
vectors expressing either full-length USSRpSS (first row), the N-terminal half of the protein 
comprising the RS domain (second row), the C-terminal half of the protein (third row), 
or the empty vector (fourth row). (B) A cartoon illustrates the primary structure, main 
features and amino acid length of the interactors found in the two-hybrid screen. The 
portions of each protein covered by selected clones are indicated by bars (with the N- and 
C- terminal amino acid numbers shown). The known features of the proteins are described 
on the right.
The Luc? gene was identified in yeast in a synthetic lethal screen with the nuclear cap 
binding complex (CBC), and was shown to be a component of the U1 snRNP and to be 
involved in 5' site selection (Fortes et al., 1999). The Luc7 protein contains arginine-serine 
and arginine-glutamic acid repeat sequences characteristic of SR and SR-related proteins 
and two zinc finger motifs. Luc7 seems to have undergone duplications several times 
during evolution, and three Luc7 genes (Luc7a-c) are present in the human genome. 
Interestingly, human Luc7 does not seem to be a stable U1 snRNP component in humans. 
CR0P/Luc7a was isolated as an overexpressed gene in a cisplatin-resistant cell line (Nishii 
et al., 2000). CR0P/Luc7a contains a leucine zipper-like motif and a carboxy terminal RS 
domain. HCCl, a 64 kDa nuclear autoantigen that harbors splicing factor motifs, was 
originally identified using an autoantiserum from a hepatocellular carcinoma patient (Imai 
et al., 1993). HCCl localizes to the nuclear speckles and contains an N-terminal RS 
domain, and three RRMs. The modular structure of HCCl and the presence of an 
octapeptide sequence, the RS-ERK motif, within its RS domain is reminiscent of the large 
subunit of the U2AF splicing factor, U2AF^^. Another interacting protein, SON, contains a 
domain rich in RS dipeptides and localises to nuclear speckles. This protein also contains a 
series of domains defined by reiterated peptide repeats, which are unique to this protein and 
are not found in any other proteins in the databases. However, its function in RNA 
processing is presently unknown (Wynn et al., 2000). Finally, a fourth factor containing an 
RS domain encoded by a novel cDNA, Rik270043I21, was isolated. The function of this 
factor is completely unknown.
All the identified interacting proteins contain an RS domain, and in every case, the 
portion of the interacting protein that is expressed as a fusion with the activation domain of 
the GAL4 transcription factor contains at least part of this domain (Fig. 16B). This fact 
suggested that the interactions observed were mediated directly by these RS domains. In
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order to verity this, constructs expressing deleted versions of USSRp58 fused to the DNA 
binding domain of GAL4 were prepared, co-transformed in AH 109 with each of the library 
plasmids isolated from the screen, and tested for the activation of the reporters. Except for 
HCCl, all the factors showed positive interaction with the RS domain of USSRp58. 
Surprisingly, the C-terminus of USSRp58 seemed to mediate the interaction with HCCl. 
This is reminiscent of the interaction described between U2AF^^ and U2AF^^, where the 
interaction between the two RS domain-containing proteins is not mediated by their RS 
domains (Zhang et al., 1992).
A group of well studied splicing factors including U170K, U2AF^^, U2AF^^ and 
SFl, were tested for their ability to interact with USSRp58. The plasmids expressing these 
proteins as a fusion with the activation domain of GAL4 transcription factor (Davies et al., 
1998) were kindly provided by Prof. Nick Hastie. As it can be seen in Fig. 17A, USSRp58 
was able to interact exclusively with U2AF^^, and again, this interaction was mediated by 
its RS domain.
Next, another group of RS domain-containing proteins that have a well-characterised 
role in splicing was tested for their ability to interact with USSRp58. Full-length cDNAs 
for several members from the SR protein family were subcloned in the pACT2 vector 
(Clontech), and co-transformed into AH 109 in combination with the different constructs 
expressing either full-length or deletion mutants of USSRp58 to test their ability to interact 
(Fig. 17B). The SR proteins SF2/ASF and SRp40 were able to interact with full-length 
USSRp58. These interactions seemed to be mediated by their RS domain, since they could 
interact with the N-terminus of USSRp58, but not with the C-terminus. In contrast, when 
SRp55, SRp20, 9G8 or SRp30c were expressed as preys, no interaction with USSRp58 was 
detected. These data indicate that USSRp58 has specificity for SF2/ASF and SRp40 RS 
domains, and that it does not simply bind to any RS domain. Taken together, these results
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Figure 17; USSRpSS interacts with splicing factors in a yeast two-hybrid system.
Interactions between wild-type or mutant versions of USSRpSS and different splicing 
factors were tested. (A) Yeast cells were co-transformed with prey plasmids encoding 
different splicing factors (indicated above) with bait vectors expressing either full-length 
USSRpSS (first row), the N-terminal half of the protein comprising the RS domain 
(second row), the C-terminal half of the protein (third row), or the empty vector (fourth 
row), and were tested for their ability to grow in the absence of Adenine. (B) Interactions 
between wild-type or mutant versions of USSRpSS and different SR proteins were 
tested as described in (A). In all cases shown in (A) and (B), activation of ADE3 reporter 
correlated with activation of MELl reporter (data not shown).
strongly suggest a role for USSRpSS in pre-mRNA splicing. Furthermore, the fact that 
USSRpSS interacts with U2AF^^ but not with U1-70K suggest a possible role for USSRpSS 
in 3' splice site selection.
3.1.8. USSRpSS interacts in vivo with splicing factors
I confirmed the two-hybrid interactions of USSRpSS with Luc7p and with SF2/ASF 
by co-immunoprecipitation (Co-IP) experiments from human 293T cell extracts. Full- 
length hLuc7a was subcloned in the mammalian expression vector, pCGT7 that has been 
previously described (Caceres et al., 1997), and following transfection into 293T cells, 
extracts were immunoprecipitated with a monoclonal antibody against the T7-tag. The 
immunoprecipitated proteins were then separated on SDS-PAGE, blotted, and detected with 
an anti-USSRpSS antibody. As shown in Fig. ISA, hLuc7a was able to pull down 
USSRpSS. This interaction seemed to be specific, since USSRpSS was not pulled down 
when anti-T7 mAb coupled to Sheparose beads was incubated with extracts from mock- 
transfected cells. Furthermore, this interaction is not RNA-mediated, since treatment with 
ribonuclease A did not abolish this interaction.
Furthermore, SF2/ASF was detected in an immunoprecipitate from 293 T cells 
immunoprecipitated with anti-USSRpSS antibodies (Fig. ISB). Again, this interaction was 
not mediated by RNA. Taken together, these results confirm the interaction data obtained 
with the yeast two-hybrid system and demonstrate that this novel SR-related protein 
functionally interacts with splicing factors.
3.1.9. USSRpSS specifically associates with a subset of snRNFs
Two-hybrid and co-immunoprecipitation data showed that USSRp58 interacts with 
Luc7a, a protein that is an integral component of the U1 snRNP particle in yeast, and also
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Figure 18: USSRp58 interacts with splicing factorsin cultured mammalian cells.
(A) Immunoprécipitation assays with T7-hLuc7a. Extracts prepared from 293T cells 
either transiently transfected with a plasmid encoding T7-hLuc7a (lanes 2 and 3) or 
mock transfected (lane 4) were incubated with anti-T7 antibody bound to Sepharose 
beads (Novagen). The bound proteins were separated on a 10% SDS-polyacrylamide 
gel, transferred to a PVDF membrane and probed with anti-USSRp58B4 antibody. 
Alternatively, the immunoprecipitate was treated with RNAse before loading on the 
gel (lane 3). Lane 1 was loaded with 2% of the amount of extract used for each 
immunoprécipitation. (B) Extracts prepared from 293T cells were incubated with either 
anti-USSRp58B4 antibody (lanes 2 and 3) or pre-immune serum (lane 4) bound to 
Sepharose beads, and analysed as described in (A). The blot was probed with mAb 96 
antibody, which recognises SF2/ASF (Hanamura et al., 1998). Alternatively, the 
immunoprecipitate was treated with RNAse before loading on the gel (lane 3). Lane 
1 was loaded with 2% of the amount of extract used for each immunoprécipitation.
with HCCl, a U2AF65-like factor. Therefore, I sought to investigate whether this novel 
SR-related protein was associated with snRNP particles, by performing 
immunoprécipitations at various salt concentrations using antibodies against the USSRp58 
protein. Co-precipitated RNAs were phenol-extracted, labelled with [^^P]pCp, fractionated 
by urea-PAGE and detected by autoradiography. Since U6 snRNA is not labeled efficiently 
with [^^P]pCp (Lund and Dahlberg, 1992), its presence was detected by Northern blot 
hybridization. For comparison, immunoprécipitations were performed with anti-USSRp5 8 
antibody pre-absorbed with PEP2.
Surprisingly, antibodies against USSRp58 efficiently precipitated U2, U4, U5 and U6 
snRNAs when the incubation and washes were done in the presence of 150 mM NaCl (Fig. 
19, lane 2), suggesting that this protein is associated with these snRNPs in splicing 
conditions. Although some U1 snRNA is precipitated with anti-USSRp58 antibodies, it is 
not enriched in the precipitate compared to the precipitate obtained with Y12 antibody (Fig. 
19, lane 1), as is the case for U2, U4, U5 and U6 snRNAs. When the incubation and washes 
were done in the presence of 250 mM NaCl, all these interactions were abolished, 
suggesting that the protein is not a stable component of any of these snRNPs. These 
interactions were specific, since no snRNAs were immunoprecipitated when the antibody 
was pre-absorbed with PEP2. These results demonstrate that USSRp58 is associated with a 
subset of snRNPs in splicing conditions. Based on this results, I decided to call the protein 
USSRp58, for U snRNP SR-related protein of 58 kDa. These results suggest that USSRp58 
could have a role in late events in spliceosome assembly and it could also be involved in 
splicing catalysis as part of the active spliceosome.
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Figure 19; Immunoprécipitation of snRNPs associated with USSRp58. HeLa 
nuclear extracts were immunoprecipitated at the salt concentrations indicated above 
the lanes, with Y12 antibody (lane 1), which recognises Sm proteins, anti-USSRp58AP2 
antibody (lanes 2 and 3) or anti-USSRp58AP2 antibody pre-absorbed with PEP2 (lanes 
3 and 4). Co-precipitated RNAs were extracted, labeled with [^^P]pCp, fractionated 
by 10% urea-PAGE and detected by autoradiography. The positions of the snRNAs 
are indicated on the left. Since U6 snRNA is not labelled efficiently with [^^P]pCp, 
its presence was detected by Northern blot hybridization (lower panel).
3.1.10. USSRpSS d o e s  not com plem ent sp lic in g-d efic ien t SI GO HeLa extracts
SF2/ASF, the prototype member of the SR protein family was identified based on its 
ability to complement an otherwise inactive cytosolic HeLa S I00 extract (Krainer et al., 
1990b; Zahler et al., 1992). Subsequently, the ability of individual SR proteins to 
complement S I00 extracts has been adapted as the standard assay to test their activity in 
constitutive splicing. In contrast to SR proteins, USSRp58 was unable to restore splicing of 
the P-globin splicing reporter in S I00 extracts (Fig. 20A). Total SR proteins purified from 
HeLa cells could support the splicing of the El A reporter when added to SI 00 extracts as 
well (Fig. 20B). When purified recombinant his-myc-USSRp58 was added to SlOO extracts 
in the presence of bulk SR proteins, a repression in the use of the proximal 13S 5' splice site 
was observed, recapitulating the effect observed in the in vivo experiments (Figures 2OB 
and see below. Fig. 22). These data suggest that one possible function of USSRp58 could 
be to negatively regulate the effect of SR proteins. However, we can not rule out at this 
stage, a role for this protein in later steps of splicing.
3.1.11. USSRpSS is required for pre-mRNA splicing
USSRp58 interacts with a subset of snRNPs and splicing factors like U2AF^^, 
suggesting that this protein could have a role in splicing beyond simply antagonising SR 
proteins. Immunodepletion of USSRp58 from nuclear extracts was performed to determine 
whether USSRp58 is required for splicing in vitro. Nuclear extracts were depleted of 
USSRp58 and then tested for the ability to splice a fushi ta razu -àQ Û V Q à  RNA substrate. A 
Western blot of control and immunodepleted extracts, probed with anti-USSRp5 8 antibody, 
is shown in Figure 21 A. After three rounds of depletion at IM KCl with anti-USSRp58
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Figure 20: USSRpSS does not complement splicing-deficient SlOO extracts and can 
regulate 5’ splice site selection in vitro, (A) In vitro splicing was performed with a 
beta-globin slicing reporter. SlOO splicing deficient extracts were supplemented with 
either 560 ng of His-Myc-USSRp58 (lane 2) or 250 ng of bulk SR proteins purified 
from HeLa cells (lane 3). The positions of pre-mRNA and spliced mRNA are indicated 
schematically on the right. (B) In vitro splicing of the El A reporter was performed in 
SlOO extracts supplemented with 250 ng of bulk SR proteins (lanes 2-4) and increasing 
amounts of His-Myc-USSRp58 (lanes 3 and 4). The positions of pre-mRNA and splice 
products are indicated schematically on the right.
177.3
110.7
79.8 
61.0
47.8
35.9
24.5
B
DEPLETED DEPLETED
® 2  $  g
^  ;  " â ;
c  nr fc
UNTREATED NE(%) §0 E CO E
^  Î  m ^  i
s o .  z  a  CLCM T- If)
m  ^  ^
1 2 3 4 5 6 7
w  m
1— I
m  m
z 2 l
1 2 3
Figure 21: Effect of USSRpSS immunodepletion on pre-mRNA splicing in vitro,
(A) The extent of USSRp58 depletion from HeLa nuclear extracts was assayed by 
Western blot analyses with an anti-USSRp58 antibody in serial dilutions of untreated 
extracts (lanes 1-5), extracts depleted with anti-USSRp58B4 antibody (lane 6) or pre- 
immune serum-depleted extracts (lane 7). Protein size markers (kDa) are indicated on 
the left. The uncharacterised protein that cross-reacts with anti-USSRp5 8 antibodies is 
indicated with an asterisk. (B) Effect of immunodepletion of USSRp58 on the splicing 
offushi tarazu (ftz) splicing reporter. Ftz pre-mRNA was incubated in untreated nuclear 
extract (lane 1), USSRp58-depleted extract (lane 2) or extract depleted with pre-immune 
serum (lane 3). Positions of spicing intermediates and products are indicated on the right.
antibody, the concentration of the protein in the extract was reduced by at least 95%, 
whereas it was not significantly depleted with the pre-immune antibody. Splicing of ftz  
RNA was assayed with untreated, pre-immune depleted and anti-USSRp5 8 depleted 
extracts (Fig. 2IB). Treatment with pre-immune serum resulted in a relative accumulation 
of intermediate products and a lower yield of spliced product when compared to the 
untreated extracts. These effects may, however, be related to nonspecific (e.g., dilution) 
effects of the depletion procedure. Nevertheless, pre-immune depleted extracts were able to 
carry out splicing, as it was revealed by the accumulation of spliced product. In contrast, 
when splicing of ftz  RNA was assayed with U S SRp5 8-depleted extracts, no accumulation 
of spliced product was observed, indicating that USSRp58 is essential for splicing. The 
second step of the splicing reaction, which generates released lariat intermediate and ligated 
exons, was preferentially affected by USSRp58 depletion under these conditions, indicating 
that this protein may play a role in this step. However, we could not rule out the possibility 
that it was required for the first step as we did not detect any accumulation of the first-step 
splicing intermediates.
3.1.12. USSRpSS can regulate alternative 5’ site selection in vivo and in vitro
We investigated the role of USSRp58 in the regulation of alternative splicing in living 
cells. Modulation of alternative splice site selection can be tested in vivo by co-transfection 
of an expression vector encoding the protein of interest with an alternative spliced substrate 
reporter (Caceres et al., 1994). Wild-type USSRp58 was overexpressed in HeLa cells and 
changes in the patterns of alternative splicing of an adenovirus El A splicing reporter, that 
contains three alternative 5' splice sites, were assayed (Fig. 22A). In agreement with 
previous results, wild-type SF2/ASF strongly activated the 13*5 5’ splice site (Caceres et al..
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Figure 22: USSRpSS can regulate 5’ splice site selection in vivo. In vivo splicing analyses 
were performed with HeLa cells transiently co-transfected with an adenovirus El A reporter 
plasmid and expression plasmids encoding for either mouse USSRp58, hnRNP A1 or 
SF2/ASF. (A) Diagram of the El A reporter gene. The alternative 5’ splice sites and splicing 
events that generate 13^, 12S, and 9S mRNAs are shown schematically. The location of 
the exon primers used for RT-PCR analysis is shown. (B) HeLa cells were transiently co­
transfected with the adenovirus E l A reporter plasmid and the expression constructs for 
each of the proteins indicated above or the parental plasmid (control). RNA was harvested 
at 24 hr post-transfection and analyzed by RT-PCR with a labelled forward primer, 
denaturing PAGE and autoradiography, as described in Materials and Methods. The 
positions of the unspliced pre-mRNA, and of 13S, \2S, and 9S spliced mRNAs are indicated 
on the right. The 10*S and 11^ isoforms (*) do not arise from competition between alternative 
5’ splice sites. (C) Quantitation of El A mRNA isoforms in transfected cells. The relative 
amounts of 13Y, 12^, and 9*5 El A mRNAs were calculated from the data in (B), using a 
Phosphorlmager, and the percentage of each isoform is shown. Each experiment was 
repeated four times and the data represent averages, with bars indicating standard errors.
1994). In contrast, increased expression of USSRp58 resulted in activation of the most 
distal 5'splice site, giving rise to the 9S isoform, as observed for hnRNP A1 (Caceres et al., 
1994). Quantitation of the relative use of the El A 5’ splice sites upon overexpression of the 
different proteins is shown in Fig. 22C. As it was shown in section 3.1.7 and 3.1.8, 
USSRp58 interacts with some SR proteins, such as SF2/ASF and SRp40. Therefore, the 
alternative splicing modulation effect shown by USSRp58 could result from the repression 
of the activity of SR proteins, such as SF2/ASF, which promotes the use of the proximal 
alternative 5' splice site.
Taken together, these results suggest that USSRp58 is a novel SR-related protein, 
associated with several U snRNP particles that has a role both in constitutive and 
alternative splicing.
105
3.2. Identification of a nuclear retention signal in the RS domain of 
non-shuttiing SR proteins
As it was mentioned in the Introduction of this thesis, a subset of SR proteins shuttles 
continuously between the nucleus and the cytoplasm. The group of shuttling SR proteins 
include SF2/ASF, Srp20 and 9G8, whereas SC35 and SRp40 are restricted to the nucleus 
(Caceres et al., 1998). It was demonstrated that the shuttling proteins SRp20 and 9G8 
promote the export of intronless RNAs in both mammalian cells and Xenopus oocytes 
(Huang and Steitz, 2001). More recently, these SR proteins and also SF2/ASF, which also 
shuttles between the nucleus and the cytoplasm, were shown to interact directly with the 
major receptor for bulk mRNA export to the cytoplasm, TAP/NXFl (Huang et al., 2003), 
suggesting a role for SR proteins as adapters in mRNA export. SF2/ASF has also been 
shown to control the stability of a PKCI-1 related mRNA (Lemaire et al., 2002). At present, 
it is not known if shuttling SR proteins have other roles in the cytoplasmic fate of mRNAs. 
It has been speculated that they could have roles in translational regulation (Caceres et al., 
1998). It has also been suggested that this mechanism could be used by the cell to modulate 
the concentration of SR proteins in the nucleus, thus possibly affecting the splicing of some 
mRNAs, as it has been shown for some SR proteins antagonists, like hnRNP A1 (van der 
Houven van Oordt et al., 2000).
The mechanism by which some SR proteins shuttle between the nucleus and the 
cytoplasm is not clear. By swapping the corresponding domains between shuttling and non­
shuttling SR proteins, it was shown that the RS domain of shuttling SR proteins is required 
for shuttling (Caceres et al., 1998). For example, a chimeric protein composed of the RS
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domain of SF2/ASF (a shuttling protein) and the RRM of SC35 (a non-shuttling protein), 
can shuttle. However, the RS domain of shuttling SR proteins is not sufficient to promote 
the nuclear export of these proteins because it can not confer the ability to shuttle to a 
nucleoplasmin core domain reporter (Caceres et al., 1998). Nevertheless, the RS domain of 
shuttling SR proteins can act as nuclear export signal (NLS) when fused to an RRM 
(Caceres et al., 1998)
The results described above suggested that some SR proteins fail to be exported from 
the nucleus because they either lack a NLS or because they contain a nuclear retention 
signal (NRS). When the RS domain of SC35 was fused to hnRNP A1 (a shuttling protein) 
or to SF2/ASF, the resulting fusion proteins were not able to shuttle (see Fig. 4 in Cazalla et 
al., 2002), suggesting that the second hypothesis is the correct one.
To determine more precisely this putative NRS in the RS domain of SC35, two C- 
terminal deletions were made and were tested to see if they could relieve nuclear retention. 
These deletion mutants lack the last 45 and 30 amino acids and were designated SC35- 
RSld and SC35-RS2d, respectively (Fig. 23A). When tested in interspecies heterokaryon 
assay, these two mutant proteins were able to shuttle between the nucleus and the 
cytoplasm (Fig. 23B). Thus, deletion of the last 30 amino acids of SC35 (SC35-RS2d) 
relieved nuclear retention and allowed nucleo-cytoplasmic shuttling, confirming that this 
sequence comprises an NRS (Fig. 23C). To determine if these NRS was sufficient to confer 
nuclear retention to a shuttling SR protein, the last 30 amino acids of SC35 comprising the 
NRS were fused to SF2/ASF (Fig. 24A) and the resulting fusion protein was tested for its 
ability to shuttle. As it can be seen in Fig. 24B, the fusion protein does not shuttle between 
the nucleus and the cytoplasm, indicating that the NRS identified in the RS domain of 
SC35 is transferable, dominant, and sufficient to confer nuclear retention on NES-bearing 
proteins.
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Figure 23: C-terminal deletions in the RS domain of SC35 relieve nuclear retention.
(A) Sequences of the SC35 RS domain and of two C-terminal deletions. The long tracts 
of RS dipeptides are indicated in grey, whereas RS dipeptides outside of these tracts 
are indicated in bold. (B) Analysis of nucleocytoplasmic shuttling of SC35 deletion 
mutant proteins by transient expression in interspecies heterokaryons. Wild-type SC35 
and deletion proteins were transiently expressed in HeLa cells, which were then fused 
with NIH 3T3 cells and analysed as described in the legend to Fig. 13.The arrows 
indicate the mouse nuclei within human-mouse heterokaryons. (C) Sequence of the 
NRS present in the RS domain of SC35.
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Figure 24: The NRS sequence identified in the RS domain of SC35 is transferable.
(A) Diagram showing the structure of a chimeric protein in which the NRS identified 
in the RS domain of SC35 was fused to SF2/ASF. (B) Analysis of nucleocytoplasmic 
shuttling by transient expression in interspecies heterokaryons. Wild-type SF2/ASF and 
the chimeric protein SF2/NRS-SC35 were transiently expressed in HeLa cells, which 
were then fused with NIH 3T3 cells and analysed as described in the legend to Fig. 13. 
The arrows indicate the mouse nuclei within human-mouse heterokaryons.
Discussion
A modified gene trap strategy, based upon the subcellular localisation of the product 
of the trapped gene, is being used in our laboratory to identify novel genes with a potential 
role in RNA processing (Tate et al., 1998). Three independent avenues suggest that a novel 
RS-containing protein, USSRp58, has a role in pre-mRNA. processing:
L  Analysis of USSRp58 sequence revealed that it contains an RS domain, which is 
diagnostic of factors involved in pre-mRNA splicing, and more generally in RNA 
processing. The subcellular localisation of the endogenous USSRp58 protein, as well of 
transiently expressed epitope-tagged USSRp58 protein, revealed that this protein localises 
to nuclear speckles, which again suggests a potential role in pre-mRNA splicing.
2. Two-hybrid analysis and immunoprecipitation/Western blot assays have been used to 
demonstrate that USSRp58 interacts with different proteins that have either potential or 
clearly defined functions in splicing. Immunoprécipitation experiments revealed that 
USSRp58 also interacts with spliceosomal snRNPs, indicating that it is physically 
associated with the splicing apparatus.
3. Using in vivo and in vitro splicing assays, USSRp58 was shown to be functionally 
involved in splicing. Transient overexpression of USSRp58 in cultured cells and analysis of 
the alternative splicing of an adenovirus El A reporter indicated that the protein can 
regulate 5' splice site selection in vivo. Furthermore, nuclear extracts immunodepleted of 
USSRp58 are unable to perform splicing in vitro, suggesting that this protein is necessary 
for this process.
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A final set of results describing a nuclear retention signal in the RS domain of SC35 
was also included in this thesis. Chimeric proteins in which the RS domain of a non­
shuttling SR protein, SC35, was fused to either hnRNP A1 or SF2/ASF (both shuttling 
proteins), were used to demonstrate that an NRS was present in the RS domain of SC35. 
Analysis of deletion mutants of SC35 indicated that the NRS is comprised in the last 30 
amino acids of the protein. Finally, by fusion of the NRS found in SC35 to SF2/ASF and 
analysis of the shuttling properties of the fusion protein, this NRS was shown to be portable 
and dominant.
4.1. Structural features of USSRpSS
USSRp58 is a novel protein with sequence similarity to previously identified splicing 
factors. It contains an RS domain, a domain found in several proteins involved in 
constitutive and alternative splicing regulation, such as SR proteins and SR-related 
proteins. RS domains have been implicated in both protein-protein and protein-RNA 
interactions (Amrein et al., 1994; Hedley et al., 1995; Kohtz et al., 1994; Valcarcel et al., 
1996). We have shown that the RS domain of USSRp58 mediate protein-protein 
interactions with other RS domain-containing proteins in a yeast two-hybrid assay. The RS 
domain of USSRp58 showed specificity in these interactions, since it was able to interact 
with only two out of six members of the SR family of proteins that were tested. This 
protein also contains a short stretch of EK-rich sequence, which combined with the RS 
domain contribute extensively to the overall charge of USSRp58 and are likely responsible 
in part for the anomalous migration of the protein on SDS-PAGE. Another possible 
explanation for the difference between the predicted molecular weight of the protein and
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that observed on SDS-PAGE is the presence of post-translational modifications, most likely 
phosphorylation of the RS domain. Accordingly, SR proteins are known to run with a 
higher apparent molecular mass on SDS-PAGE because of phosphorylation of the RS 
domain (Hanamura et al., 1998). Phosphorylation of the SR domain of USSRp58 in vivo 
remains to be demonstrated.
The unusual EK-rich region is also found in SRrp86, an SR-related protein, that was 
shown to regulate the activity of several SR proteins (Barnard and Patton, 2000). By 
analysis of chimeric proteins and deletion mutants in which the EK-rich region was 
removed, it was demonstrated that this domain is responsible for the inhibitory activity on 
splicing and splice-site selection elicited by SRrp86, most likely by titrating the activity of 
required splicing factors (Li et al., 2002). This could explain the effect of USSRp58 on 5' 
splice site selection in vivo and in vitro. Thus, the short EK-rich region present in USSRp58 
could be responsible for antagonising SR proteins, affecting splice site choice in the El A 
reporter. Preliminary results showed that USSRp58 is also able to antagonise SR proteins in 
constitutive splicing in vitro (data not shown). If this is the case, a mutant version of 
USSRp58 in which this EK-rich region is absent should not be able to enhance the choice 
of the distal 5' spice site in the El A reporter and should not affect the activity of SR 
proteins on constitutive splicing either. The functional significance of this domain in 
USSRp58 will be further investigated.
USSRp58 does not contain a known RNA-binding motif. Several proteins such as 
Prp8, Prpl6, and Tra do not contain RNA-binding motifs (Brown and Beggs, 1992; 
McKeown et al., 1987; Schwer and Guthrie, 1991; Zhang et al., 1992), yet they play 
important roles in splicing and alternative splicing regulation (Brown and Beggs, 1992; Zuo 
and Maniatis, 1996). Despite lacking known RNA-binding motifs, some of these splicing 
factors do bind to RNA. Crosslinking experiments in yeast and mammals have
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demonstrated that Prp8 and its mammalian homolog p220 directly contact the pre-mRNA, 
lariat intermediate, and excised lariat intron (Garcia-Bianco et al., 1990; Teigelkamp et al., 
1995; Whittaker and Beggs, 1991). It remains to be established whether USSRp58 is able 
to bind RNA, either through its RS domain or C-terminal domain.
Surprisingly, the C-terminal half of USSRp58 mediates the interaction with HCCl in 
a yeast two-hybrid assay. This is reminiscent of the interaction described between the two 
subunits of U2AF (Zhang et al., 1992), where the RS domains present in both subunits are 
not involved in the interaction. Consistently, the overall domain structure of HCCl 
resembles that of U2AF^^ (Imai et al., 1993). Since the function of HCCl is not known at 
the moment, the significance of this interaction is unknown.
4.2. Expression and subcellular localisation of USSRp58
The expression of splicing factors is usually regulated in a tissue and developmental- 
specific manner. A classical example are the components in the cascade of alternative 
splicing events regulating the sex-determination pathway in Drosophila melanogaster 
(reviewed in Gebauer et al., 1997). Alternative splicing of a variety of pre-mRNAs can be 
also affected in vivo by the relative ratio of antagonistic splicing regulators. For example, 
members of the SR protein family and of the hnRNP A/B family of proteins, which 
antagonise each other as regulators of alternative splicing, vary naturally over a wide range 
in different tissues and cell lines (Hanamura et al., 1998). Northern blot analysis showed 
that and analysesUSSRp5 8 is widely yet differentially expressed across a variety of mouse 
adult tissues, consistent with a potential role as a splicing regulator.
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Antibodies raised against peptides derived from the USSRp58 sequence cross-react 
with a protein of approximately 68 kDa on Western blots from nuclear extracts and mouse 
tissues. This protein also seems to be widely and differentially expressed across tissues. 
The relationship of this protein to USSRp58 is not known at the moment. This band could 
be either a modified form or alternatively spliced isoform of USSRp58, although there is no 
direct evidence to suggest that it is related to USSRp58. Western blot analysis of extracts 
prepared from cells transiently transfected with pCGT7-USSRp58 showed only a single 
band, (see Fig. 11 A). Further experimentation will be required to determine the identity of 
this cross-reacting band.
When used in indirect immunofluorescence experiments, the antibodies raised against 
USSRp58 derived peptides revealed that the endogenous protein localises exclusively to the 
nucleus, and shows a speckled staining pattern. Transiently expressed epitope-tagged 
versions of USSRp58 confirmed this localisation and showed co-localisation with SC35 in 
splicing speckles. This is not surprising, since the RS domain of certain SR proteins has 
been shown to be necessary and sufficient for targeting these factors to nuclear speckles 
(Caceres et al., 1997; Hedley et al., 1995; Li and Bingham, 1991). The localisation of 
USSRp58 to nuclear speckles is highly diagnostic of its involvement of pre-mRNA 
splicing.
Several proteins that have been described to participate in pre-mRNA splicing in the 
nucleus have been shown to travel to the cytoplasm with the spliced mRNA. For some of 
them, cytoplasmic functions have been described. For instance, members of the hnRNP 
family of proteins have been reported to regulate cytoplasmic events like mRNA 
localisation, translation and mRNA turnover (reviewed in Shyu and Wilkinson, 2000). The 
splicing regulator Sxl represses the translation of msl-2 mRNA by binding to both the 5' 
and 3' untranslated regions (UTR) both in vivo and in vitro (Bashaw and Baker, 1997;
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Gebauer et al., 1999; Kelley et al., 1997). Members of the SR family of proteins have also 
been described to shuttle between the nucleus and the cytoplasm (Caceres et al., 1998), 
with the RS domain being necessary but not sufficient for this activity. USSRp58 shuttles 
between the nucleus and the cytoplasm, suggesting that this protein might play a role in 
post-splicing mRNA processing. Since it is not known if USSRp58 binds directly to the 
mRNA, an alternative possibility is that USSRp58 travels to the cytoplasm as part of 
protein complexes that are deposited on the mRNA. One example that supports this 
possibility is the SR-related protein SRml60, which does not bind directly to the pre- 
mRNA (Blencowe et al., 1998), but can be cross-linked near exon-exon junctions after 
splicing in HeLa nuclear extracts (Le Hir et al., 2000) as part of a complex called the exon- 
exon junction complex (EJC), that mark the position of exon-exon junctions. Preliminary 
experiments showed that USSRp58 co-sediments with ribosomes in sucrose gradients (data 
not shown), suggesting that the protein could be involved in translation. This possibility 
will be further investigated.
4.3. Interactions between USSRpSS and spliceosomal components
The association of USSRp58 with spliceosomal snRNPs was tested by examining the 
presence of snRNAs including U l, U2, U4, U5 and U6 in the immunoprecipitates from 
HeLa nuclear extracts formed by anti-USSRp58 antibodies. This experiment showed that 
U2, U4, U5, and U6, but not Ul snRNAs could be efficiently immunoprecipitated by anti- 
US SRp5 8 antibodies in the presence of 150 mM NaCl, suggesting that USSRp58 could be 
associated in the nucleus with these snRNPs in splicing conditions. When the 
immunoprécipitations were performed in the presence of 250 mM NaCl, no snRNAs were
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immunoprecipitated, suggesting that USSRp58 is not stably associated with these snRNPs. 
Since the anti-USSRp58 antibodies can immunoprecipitate the cross-reacting 68 kDa 
protein with the same efficiency as that observed for USSRp58 (see Fig. 21 A), the 
possibility that the 68 kDa protein is associated with these snRNPs can not be ruled out. 
Alternative methods need to be employed to determine the way these proteins associate 
with the different snRNPs. For example, fractionation of nuclear extracts by glycerol 
gradient sedimentation can be used to resolve the U l, U2, U4/U6, U5, and U4/U6-U5 
snRNPs from one another. Analysis of the resulting fractions by Western blot with the anti- 
USSRp58 antibody will indicate how these two proteins associate with the different 
snRNPs. These experiments will be performed.
Systematic examination of protein-protein interactions revealed that USSRp58 can 
directly and specifically interact with several known splicing factors. This protein-protein 
interaction profile is different from that reported for other RS domain-containing proteins 
such as SF2/ASF, SC35 or p54. For example, SF2/ASF and SC35 can both interact with 
U1-70K and U2AF^^, but not with U2AF^^ (Wu and Maniatis, 1993), whereas p54 interacts 
with SF2/ASF and U2AF^^, but can not interact with U1-70K or U2AF^^ (Zhang and Wu, 
1996). In contrast, USSRp58 interacts with SF2/ASF and U2AF^^, but can not interact with 
U1-70K or U2AF^^. This finding suggest that USSRp58 is not directly mediating 
interactions between components at the 5' and 3' splice sites, but rather interacts with 
components of the 3' splice site. As mentioned previously, USSRp58 also interacts with the 
U2AF^^ related factor, HCCl, in the yeast two-hybrid system. Although the function of 
HCCl is unknown, it can be speculated that its function could be similar to that of U2AF^^, 
since it is structurally related to this factor (Imai et al., 1993). It has been speculated that 
mammalian cells contain multiple U2AF-like complexes (Shepard et al., 2002). If that is 
the case, USSRp58 could mediate the interaction between U2AF^^ and HCCl, if these two
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proteins are unable to interact directly. It would be interesting to determine if USSRp58, 
HCCl and U2AF^^ are part of the same complex.
USSRp58 also interacts with Luc7a, the human counterpart of Luc7p, a yeast protein 
shown to be a stable component of Ul snRNP (Fortes et al., 1999). Up to date, there are no 
reports describing the functional characterisation of mammalian Luc7a, thus, it is difficult 
to ascertain the functional significance of this interaction. . The fact that Luc7p is part of 
Ul snRNP in yeast suggests that Luc7a could be associated with Ul snRNP in mammals. 
USSRp58 interacts with Luc7a, yet antibodies against USSRp58 are unable to pull down 
U l snRNA efficiently. This discrepancy could be explained in two different ways. One 
possibility is that Luc7a is not associated with Ul snRNP at the salt concentrations at which 
the immunoprécipitation with anti-USSRp5 8 antibodies was performed. The other 
explanation could be that USSRp58 interacts with a pool of Luc7a that is not associated 
with Ul snRNP. It remains to be established which explanation is correct.
4.4. The role of USSRpSS in splicing
A role for USSRp58 in splicing was first suggested by the observation that nuclear 
extracts depleted from USSRp58 are unable to perform splicing. The accumulation of exon 
1 intermediate to similar levels as those shown by the extract depleted with the pre-immune 
serum would suggest that the USSRp58-depleted extracts can perform the first step of 
splicing. However, at present we can not rule out a role for USSRp58 during the first 
catalytic step. As it was mentioned before, the 68 kDa protein that cross-reacts with anti- 
USSRp58 antibodies is co-depleted with USSRp58 from these extracts. Therefore, the 
possibility that the arrest of splicing is due to the absence of the 68 kDa can not be 
disregarded. Addition of recombinant USSRp58 to the depleted extracts should restore full
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splicing activity if USSRp58 is the only factor responsible for the splicing deficiency 
observed. These experiments are currently under progress. Since the depleted extracts were 
tested only on one pre-mRNA, it can not be concluded that the activity depleted with anti- 
US SRp5 8 antibodies is generally required for splicing. More splicing reporters need to be 
tested in order to establish the general requirement of this activity for splicing.
The catalytically active spliceosome for both steps of the splicing reaction is normally 
referred to as the C complex. This complex can be observed as a discrete band in native 
gels (Das and Reed, 1999). However, different configurations of the C complex must exist 
because the two transestérification steps require different reactive groups (see Staley and 
Guthrie, 1998). This is supported by the observation that in the absence of hSlu7, a protein 
required for the second catalytic step, splicing is arrested in between the catalytic steps in a 
new complex, designated the C^ hsiu? complex (Chua and Reed, 1999). One explanation for 
the potential requirement of USSRp58 for the second catalytic step is that the protein is 
essential to perform the conformational rearrangements that occur between the first and the 
second catalytic steps of spicing.
Genetic and biochemical data demonstrate that the second catalytic step of splicing 
requires a unique set of interactions that is distinct from those occurring during spliceosome 
assembly and the first catalytic step (reviewed in Staley and Guthrie, 1998; Umen and 
Guthrie, 1995). Insight into the mechanism of step II has come mainly from work done in 
yeast. The proteins Prpl6 (Burgess et al., 1990; Couto et al., 1987; Schwer and Guthrie, 
1991), Prpl7 (Jones et al., 1995; Vijayraghavan et al., 1989), Prpl8 (Horowitz and 
Abelson, 1993; Vijayraghavan and Abelson, 1990) and Slu7 (Ansari and Schwer, 1995; 
Frank and Guthrie, 1992; Jones et al., 1995) functions exclusively in step II, and Prp8 
functions in both step I and step II (Brown and Beggs, 1992; Teigelkamp et al., 1995). 
Prp22, a protein involved in the release of spliced mRNA, also plays a role in step II
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(Schwer and Gross, 1998). In humans, homologs of the step II factors Prpl6, Prpl7, Prpl8 
and Slu7 have been identified and shown to be general step II splicing factors (Ben Yehuda 
et al., 1998; Chua and Reed, 1999; Horowitz and Krainer, 1997; Lindsey and Garcia- 
Bianco, 1998; Zhou and Reed, 1998). Thus, splicing factors important for step II are 
conserved from yeast to humans. However, although splicing in yeast and mammals 
follows similar overall pathways, there are some notable differences. The mechanism for 
recognising splice sites in mammals, which allows for a wide variation in splice site 
sequences and for regulated alternative splicing, is more complex than that of yeast, where 
splice-site sequences are nearly invariant and alternative splicing is absent (Black, 1995; 
Horowitz and Krainer, 1994). Identification of 3' splice sites, which occurs during the 
second step, is therefore likely to occur by somewhat different mechanisms in mammals 
and yeast. Therefore, is not surprising that mammalian specific factors are required for the 
second step of splicing.
After the first catalytic step has occurred, the 3' splice site needs to be identified by 
the spliceosome in order to proceed with the second step of splicing. In mammals, both the 
branch site and the polypyrimidine tract are required for both the first and second catalytic 
steps. (Umen and Guthrie, 1995). This requirement is easily obscured by the strong 
requirement for the polypyrimidine tract in spliceosome assembly prior to the first catalytic 
step. However, with the appropriate substrate, a role for the polypyrimidine tract in the 
second catalytic step has been uncovered (Reed, 1989). In yeast, the functional role in the 
second step of the polypyrimidine tract was also demonstrated (Patterson and Guthrie, 
1991). Accordingly, a PTB associated splicing factor (PSF) has been shown to be required 
for the second catalytic step in mammals (Garcia-Bianco et al., 1989; Patton et al., 1993). 
PSF is a polypyrimidine tract binding protein associated with PTB that has only been 
required for the splicing of a pre-mRNA derived from the a-tropomyosin pre-mRNA. This
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substrate has an unusual branch point, located far form the 3' splice site, just upstream of a 
second pyrimidine tract (Smith and Nadal-Ginard, 1989), thus the role of PSF as a general 
second step is controversial. Possibly, different factors are required to identify different 3' 
splice sites prior to the second catalytic step. In this scenario, a complex formed by HCCl, 
USSRp58 and U2AF^^ could have a role recognising the pyrimidine and defining the 3’ 
splice site of certain substrates after the first catalytic splicing has occurred. Further 
experimentation will be required to test this hypothesis.
USSRp58 was also shown to regulate 5' splice site selection in the E l A splicing 
reporter in vivo and in vitro. Mechanistically, the functional antagonism shown by 
SF2/ASF and hnRNP A1 on 5' splice selection in this reporter (Caceres et al., 1994) is 
based on competitive binding to pre-mRNA. SF2/ASF interferes with hnRNP A1 binding 
and promotes U l snRNP binding at all sites, resulting in the selection of the 5' proximal 
site. In contrast, hnRNP A1 binds co-operatively and indiscriminately to the El A reporter 
repressing the Ul snRNP binding at all sites, resulting in a shift to the distal 5' splice site 
(Eperon et al., 1993; Eperon et al., 2000). USSRp58 promotes the selection of the distal 5' 
splice sites both in vivo and in vitro, resembling the activity shown by hnRNP A l. Since 
USSRp58 does not interact directly with Ul snRNP as suggested by the protein-protein and 
protein-RNA interaction profiles described in this thesis, a direct role in the regulation of 
Ul snRNP binding to the different 5' splice sites seems unlikely. USSRp58 could instead 
promote selection of the distal 5' splice site in the El A reporter by titrating SR proteins that 
were shown to interact with USSRp58, such as SF2/ASF. It is also possible that the short 
EK-rich present in USSRp58 might play a prominent role in the repression of the activity of 
such SR proteins. Further experimentation will be needed to validate this hypothesis.
120
4.5. Nuclear retention signals In the RS domains of non-shuttling 
SR proteins
Results presented in this thesis showed that SC35 is restricted to the nucleus not 
because it lacks a nuclear export signal (NES) but because it contains a nuclear retention 
signal (NRS). There is little information about nuclear retention of proteins. Specific 
sequences that mediate the retention of proteins in the nucleus have been described, such as 
the one that directs the localisation of the shuttling protein nucleolin to the nucleolus 
(Schmidt-Zachmann et al., 1993) or a region of approximately 200 amino acids that 
mediates the nuclear retention of the La protein (Simons et al., 1996). However, in none of 
these cases has it been shown whether these proteins have transferable NRSs capable of 
conferring nuclear retention on proteins that contain NES s.
An NRS was identified in hnRNP C l, a non-shuttling hnRNP (Nakielny and 
Dreyfuss, 1996), supporting the idea that non-shuttling hnRNPs are confined to the nucleus 
due to signals that actively promote their nuclear retention. The hnRNP Cl NRS was the 
first sequence shown to retain NES-bearing proteins in the nucleus. It comprises a core 
NRS sequence of 58 amino acids that requires approximately 10 amino acids at both the 
amino and the carboxyl termini for full NRS function. This proline-rich NRS sequence 
contains clusters of basic residues, potential phosphorylation sites for casein kinase II and 
protein kinase C, and a potential glycosylation site (Nakielny and Dreyfuss, 1996).
Carboxyl terminal deletions in the RS domain of SC35 showed that the NRS is 
contained within a 30-amino acid segment at the C-terminus of the RS domain, comprising 
a proline-rich sequence. The human SC35 NRS sequence is portable and dominant, since it 
confers nuclear retention to the shuttling protein SF2/ASF. Other than this proline-rich
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composition, there is no discernible sequence similarity between the NRS sequences 
identified in hnRNP Cl and SC35. Both sequences are proline and serine rich and basic in 
character, at least in the absence of phosphorylation. SRp40, which is also retained in the 
nucleus and has multiple consecutive RS repeats (Caceres et al., 1998), does not contain a 
sequence with obvious similarity to the SC35 NRS. Interestingly, the Drosophila homolog 
of human SC35, which unlike its human counterpart has a short RS domain and shuttles 
between the nucleus and the cytoplasm, lacks this NRS sequence (Jamal Tazi, personal 
communication). Most likely, nuclear retention is mediated by interactions of the NRS with 
nuclear components which are yet to be defined.
4.6. Future perspectives
Many questions remain open about the possible roles of USSRp58 in pre-mRNA 
splicing. Further analysis of the roles of the RS and the EK-rich domains in mediating 
interactions with SR proteins are required. It also remains to be established whether the RS 
domain of USSRp58 is phosphorylated in vivo, and how this phosphorylation affects its 
activity.
It would also very interesting to investigate the significance of the shuttling activity 
of USSRp58 and the possible roles of this protein in the cytoplasm. Fractionation of 
cytoplasmic extracts by sucrose gradient sedimentation and analysis of the fractions by 
Western blot with the anti-USSRp58 antibody have shown that USSRp58 co-sediments 
with 80S ribosomes and with polysomes, suggesting a role involved in translation of 
mRNAs in the cytoplasm (data not shown). Even though the yeast two-hybrid screen did 
not reveal interactions with known translation factors, USSRp58 interacts with SR proteins,
122
which have a role in translation (Jeremy Sanford and Javier Caceres, unpublished results). 
The functional significance of the association of USSRp58 with the translation machinery 
will be pursued.
It would also be very interesting to determine gene targets which expression can be 
affected by USSRp58. A good approach that could be used to identify mRNAs associated 
with USSRp58 is to perform immunoprécipitation experiments with anti-USSRp5 8 
antibodies from nuclear and cytoplasmic fractions followed by identification of the mRNAs 
present in the immunoprecipitates by microarray analyses.
One essential question that needs to be answered is the identity of the 68 kDa protein 
that cross-reacts with anti-USSRp58 antibodies. Since this protein is efficiently 
immunoprecipitated by anti-USSRp5 8 antibodies, immunoprécipitation experiments 
coupled with SDS-PAGE fractionation and mass spec analysis are currently being 
performed to assess the identity of this protein. Another question that remains unexplored is 
the ability of USSRp58 to bind directly to RNA. Cross-linking experiments in vivo and in 
vitro will be performed to elucidate this possibility.
The potential requirement and function of USSRp58 during the second catalytic step 
of splicing is perhaps the most intriguing question remaining open. Is USSRp58 necessary 
for the spliceosome to undergo the conformational changes occurring during the second 
catalytic step? Does USSRp58 play a role in the selection of the 3' splice site prior to the 
step II of splicing? If this is the case, what is the significance of its interaction with HCCl 
and U2AF^^? Are there complexes analogous to U2AF needed for the recognition of the 3' 
splice site during the second catalytic step of splicing? Great effort will be put in answering 
these questions in the near future.
Finally, it would be interesting to determine the nuclear factors that could mediate the 
retention of SC35 in the nucleus. A yeast two-hybrid screen using the NRS found in SC35
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as a bait is currently being performed to answer this question. It was shown that SC35 can 
be cross-linked to poly(A)+ RNA in the nucleus but not in the cytoplasm, indicating that 
SC35 is removed from the spliced mRNA before it exits the nucleus (Huang and Steitz, 
2001). It would be also important to define whether the NRS plays a role in the selection of 
SC35 as a protein to be removed from spliced mRNAs before they leave the nucleus. It has 
also been shown that shuttling SR proteins interact with TAP/NXFl (Huang et al., 2003), 
functioning as adapters proteins for TAP-dependent mRNA export. It would be important 
to determine whether the NRS found in the RS domain of SC35 has a role in preventing the 
interaction of SC35 with TAP/NFXl.
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